{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:57:15Z","timestamp":1790585835734,"version":"4.1.0"},"reference-count":377,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011878","name":"Vlaamse regering","doi-asserted-by":"publisher","award":["Methusalem Program"],"award-info":[{"award-number":["Methusalem Program"]}],"id":[{"id":"10.13039\/501100011878","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"DOI":"10.1007\/s00204-026-04541-6","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:58:38Z","timestamp":1790477918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["New approach methodologies for in vitro detection of chemical-induced cholestatic liver injury"],"prefix":"10.1007","author":[{"given":"Amy","family":"Maerten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra-Costina","family":"Av\u00eervarei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Vinken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"4541_CR1","doi-asserted-by":"publisher","unstructured":"European Chemicals Agency, New approach methodologies in regulatory science \u2013 Proceedings of a scientific workshop \u2013 Helsinki, Helsinki, 2016. https:\/\/data.europa.eu\/doi\/https:\/\/doi.org\/10.2823\/543644 (Accessed May 5, 2026).","DOI":"10.2823\/543644"},{"key":"4541_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41684-026-01731-8","author":"A Ahluwalia","year":"2026","unstructured":"Ahluwalia A, Fletemeyer B, Chirico G, Elezovic A, Neuhaus W, Smith AJ, Bajramovic JJ, Wilflingseder D (2026) What\u2019s in a NAM? Lab Anim. https:\/\/doi.org\/10.1038\/s41684-026-01731-8","journal-title":"Lab Anim"},{"key":"4541_CR3","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/S00204-019-02492-9","volume":"93","author":"W Albrecht","year":"2019","unstructured":"Albrecht W, Kappenberg F, Brecklinghaus T, Stoeber R, Marchan R, Zhang M, Ebbert K, Kirschner H, Grinberg M, Leist M, Moritz W, Cadenas C, Ghallab A, Reinders J, Vartak N, van Thriel C, Golka K, Tolosa L, Castell JV, Damm G, Seehofer D, Lampen A, Braeuning A, Buhrke T, Behr AC, Oberemm A, Gu X, Kittana N, van de Water B, Kreiling R, Fayyaz S, van Aerts L, Smedsr\u00f8d B, Ellinger-Ziegelbauer H, Steger-Hartmann T, Gundert-Remy U, Zeigerer A, Ullrich A, Runge D, Lee SML, Schiergens TS, Kuepfer L, Aguayo-Orozco A, Sachinidis A, Edlund K, Gardner I, Rahnenf\u00fchrer J, Hengstler JG (2019) Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations. Arch Toxicol 93:1609\u20131637. https:\/\/doi.org\/10.1007\/S00204-019-02492-9","journal-title":"Arch Toxicol"},{"key":"4541_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97160-3","volume":"11","author":"C Ambrus","year":"2021","unstructured":"Ambrus C, Bakos \u00c9, Sarkadi B, \u00d6zvegy-Laczka C, Telbisz \u00c1 (2021) Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics. Sci Rep 11:17810-. https:\/\/doi.org\/10.1038\/s41598-021-97160-3","journal-title":"Sci Rep"},{"key":"4541_CR5","doi-asserted-by":"publisher","first-page":"28857","DOI":"10.1074\/jbc.M011610200","volume":"276","author":"M Ananthanarayanan","year":"2001","unstructured":"Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ (2001) Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor. J Biol Chem 276:28857\u201328865. https:\/\/doi.org\/10.1074\/jbc.M011610200","journal-title":"J Biol Chem"},{"key":"4541_CR6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/etc.34","volume":"29","author":"GT Ankley","year":"2010","unstructured":"Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrrano JA, Tietge JE, Villeneuve DL (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730\u2013741. https:\/\/doi.org\/10.1002\/etc.34","journal-title":"Environ Toxicol Chem"},{"key":"4541_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1124\/dmd.109.030197","volume":"38","author":"S Anth\u00e9rieu","year":"2010","unstructured":"Anth\u00e9rieu S, Chesn\u00e9 C, Li R, Camus S, Lahoz A, Picazo L, Turpeinen M, Tolonen A, Uusitalo J, Guguen-Guillouzo C, Guillouzo A (2010) Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells. Drug Metab Dispos 38:516\u2013525. https:\/\/doi.org\/10.1124\/dmd.109.030197","journal-title":"Drug Metab Dispos"},{"key":"4541_CR8","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/hep.26160","volume":"57","author":"S Anth\u00e9rieu","year":"2013","unstructured":"Anth\u00e9rieu S, El Azzi PB, Dumont J, Abdel-Razzak Z, Guguen-Guillouzo C, Fromenty B, Robin MA, Guillouzo A (2013) Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells. Hepatology 57:1518\u20131529. https:\/\/doi.org\/10.1002\/hep.26160","journal-title":"Hepatology"},{"key":"4541_CR9","doi-asserted-by":"publisher","DOI":"10.37349\/edd.2022.00008","author":"M Asensio","year":"2022","unstructured":"Asensio M, Ortiz-Rivero S, Morente-Carrasco A, Marin JJG (2022) Etiopathogenesis and pathophysiology of cholestasis. Explor Dig Dis. https:\/\/doi.org\/10.37349\/edd.2022.00008","journal-title":"Explor Dig Dis"},{"key":"4541_CR10","doi-asserted-by":"publisher","first-page":"22250","DOI":"10.1074\/JBC.M314111200","volume":"279","author":"M Assem","year":"2004","unstructured":"Assem M, Schuetz EG, Leggas M, Sun D, Yasuda K, Reid G, Zelcer N, Adachi M, Strom S, Evans RM, Moore DD, Borst P, Schuetz JD (2004) Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J Biol Chem 279:22250\u201322257. https:\/\/doi.org\/10.1074\/JBC.M314111200","journal-title":"J Biol Chem"},{"key":"4541_CR11","doi-asserted-by":"publisher","unstructured":"A.-C. Av\u00eervarei, E. Callewaert, K. Xiftou, M. Vinken, J. Sanz-Serrano, The integration of adverse outcome pathways and aggregate exposure pathways for food safety testing: pesticides as a case study, (2025) 253\u2013286. https:\/\/doi.org\/10.19103\/AS.2025.0158.19.","DOI":"10.19103\/AS.2025.0158.19"},{"key":"4541_CR12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1053\/jhep.2000.7877","volume":"31","author":"M Axelson","year":"2000","unstructured":"Axelson M, Ellis E, M\u00f6rk B, Garmark K, Abrahamsson A, Bj\u00f6rkhem I, Ericzon BG, Einarsson C (2000) Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid. Hepatology 31:1305\u20131312. https:\/\/doi.org\/10.1053\/jhep.2000.7877","journal-title":"Hepatology"},{"key":"4541_CR13","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1124\/dmd.114.058123","volume":"42","author":"P Bachour-El Azzi","year":"2014","unstructured":"Bachour-El Azzi P, Sharanek A, Abdel-Razzak Z, Antherieu S, Al-Attrache H, Savary CC, Lepage S, Morel I, Labbe G, Guguen-Guillouzo C, Guillouzo A (2014) Impact of inflammation on chlorpromazine-induced cytotoxicity and cholestatic features in HepaRG cells. Drug Metab Dispos 42:1556\u20131566. https:\/\/doi.org\/10.1124\/dmd.114.058123","journal-title":"Drug Metab Dispos"},{"key":"4541_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/toxsci\/kfv041","volume":"145","author":"P Bachour-El Azzi","year":"2015","unstructured":"Bachour-El Azzi P, Sharanek A, Burban A, Li R, Le Gu\u00e9vel R, Abdel-Razzak Z, Stieger B, Guguen-Guillouzo C, Guillouzo A (2015) Comparative localization and functional activity of the main hepatobiliary transporters in HepaRG cells and primary human hepatocytes. Toxicol Sci 145:157\u2013168. https:\/\/doi.org\/10.1093\/toxsci\/kfv041","journal-title":"Toxicol Sci"},{"key":"4541_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0168-8278(95)80261-4","volume":"22","author":"Y Bacq","year":"1995","unstructured":"Bacq Y, Myara A, Brechot MC, Hamon C, Studer E, Trivin F, Metman EH (1995) Serum conjugated bile acid profile during intrahepatic cholestasis of pregnancy. J Hepatol 22:66\u201370. https:\/\/doi.org\/10.1016\/0168-8278(95)80261-4","journal-title":"J Hepatol"},{"key":"4541_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1021\/ACS.JPROTEOME.4C00708","volume":"24","author":"J Bao","year":"2025","unstructured":"Bao J, Zhang X, Ye M, Yang Y, Xu L, He L, Guo J, Yao D, Wang S, Zhang J, Tian X (2025) Exploration of novel metabolic mechanisms underlying primary biliary cholangitis using hepatic metabolomics, lipidomics, and proteomics analysis. J Proteome Res 24:562\u2013578. https:\/\/doi.org\/10.1021\/ACS.JPROTEOME.4C00708","journal-title":"J Proteome Res"},{"key":"4541_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/toxsci\/kfv159","volume":"148","author":"JA Barber","year":"2015","unstructured":"Barber JA, Stahl SH, Summers C, Barrett G, Park BK, Foster JR, Kenna JG (2015) Quantification of drug-induced inhibition of canalicular cholyl-l-lysyl-fluorescein excretion from hepatocytes by high content cell imaging. Toxicol Sci 148:48\u201359. https:\/\/doi.org\/10.1093\/toxsci\/kfv159","journal-title":"Toxicol Sci"},{"key":"4541_CR18","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/S0016-5085(03)00388-3","volume":"124","author":"O Barbier","year":"2003","unstructured":"Barbier O, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D, Kuipers F, Kosykh V, Fruchart JC, Staels B (2003) FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 124:1926\u20131940. https:\/\/doi.org\/10.1016\/S0016-5085(03)00388-3","journal-title":"Gastroenterology"},{"key":"4541_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.115279","volume":"408","author":"A Basharat","year":"2020","unstructured":"Basharat A, Rollison HE, Williams DP, Ivanov DP (2020) HepG2 (C3A) spheroids show higher sensitivity compared to HepaRG spheroids for drug-induced liver injury (DILI). Toxicol Appl Pharmacol 408:115279. https:\/\/doi.org\/10.1016\/j.taap.2020.115279","journal-title":"Toxicol Appl Pharmacol"},{"key":"4541_CR20","doi-asserted-by":"publisher","unstructured":"S.B.J.; W.M. Batista Leite, M. Cipriano, D. Carpi, S. Coecke, M. Holloway, R. Corvi, A. Worth, J. Barroso, M. Whelan, Establishing the scientific validity of complex in vitro models, Publications Office of the European Union (2021). https:\/\/doi.org\/10.2760\/399535.","DOI":"10.2760\/399535"},{"key":"4541_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2019.104700","volume":"62","author":"AC Behr","year":"2020","unstructured":"Behr AC, Plinsch C, Braeuning A, Buhrke T (2020) Activation of human nuclear receptors by perfluoroalkylated substances (PFAS). Toxicol in Vitro 62:104700. https:\/\/doi.org\/10.1016\/j.tiv.2019.104700","journal-title":"Toxicol in Vitro"},{"key":"4541_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1053\/JHEP.2001.25958","volume":"34","author":"M Bertolotti","year":"2001","unstructured":"Bertolotti M, Carulli L, Concari M, Martella P, Loria P, Tagliafico E, Ferrari S, Del Puppo M, Amati B, de Fabiani E, Crestani M, Amorotti C, Manenti A, Carubbi F, Pinetti A, Carulli N (2001) Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans. Hepatology 34:234\u2013242. https:\/\/doi.org\/10.1053\/JHEP.2001.25958","journal-title":"Hepatology"},{"key":"4541_CR23","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.steroids.2008.05.011","volume":"73","author":"M Bertolotti","year":"2008","unstructured":"Bertolotti M, Del Puppo M, Gabbi C, Corna F, Carulli L, Pellegrini E, Zambianchi L, Anzivino C, Ricchi M, Loria P, Kienle MG, Carulli N (2008) Correlation between plasma levels of 7\u03b1-hydroxy-4-cholesten-3-one and cholesterol 7\u03b1-hydroxylation rates in vivo in hyperlipidemic patients. Steroids 73:1197\u20131202. https:\/\/doi.org\/10.1016\/j.steroids.2008.05.011","journal-title":"Steroids"},{"key":"4541_CR24","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.3390\/molecules17021939","volume":"17","author":"M Bertolotti","year":"2012","unstructured":"Bertolotti M, Crosignani A, Del Puppo M (2012) The use of stable and radioactive sterol tracers as a tool to investigate cholesterol degradation to bile acids in humans in vivo. Molecules 17:1939\u20131968. https:\/\/doi.org\/10.3390\/molecules17021939","journal-title":"Molecules"},{"key":"4541_CR25","doi-asserted-by":"publisher","first-page":"17810","DOI":"10.1074\/jbc.m209898200","volume":"278","author":"U Beuers","year":"2003","unstructured":"Beuers U, Denk GU, Soroka CJ, Wimmer R, Rust C, Paumgartner G, Boyer JL (2003) Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets. J Biol Chem 278:17810\u201317818. https:\/\/doi.org\/10.1074\/jbc.m209898200","journal-title":"J Biol Chem"},{"key":"4541_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1124\/dmd.120.000134","volume":"49","author":"YA Bi","year":"2021","unstructured":"Bi YA, Ryu S, Tess DA, Rodrigues AD, Varma MVS (2021) Effect of human plasma on hepatic uptake of organic anion\u2013transporting polypeptide 1B substrates: studies using transfected cells and primary human hepatocytes. Drug Metab Dispos 49:72\u201383. https:\/\/doi.org\/10.1124\/dmd.120.000134","journal-title":"Drug Metab Dispos"},{"key":"4541_CR27","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1053\/j.gastro.2020.06.010","volume":"159","author":"MN Bin Ramli","year":"2020","unstructured":"Bin Ramli MN, Lim YS, Koe CT, Demircioglu D, Tng W, Gonzales KAU, Tan CP, Szczerbinska I, Liang H, Soe EL, Lu Z, Ariyachet C, Yu KM, Koh SH, Yaw LP, Jumat NHB, Lim JSY, Wright G, Shabbir A, Dan YY, Ng HH, Chan YS (2020) Human pluripotent stem cell-derived organoids as models of liver disease. Gastroenterology 159:1471-1486.e12. https:\/\/doi.org\/10.1053\/j.gastro.2020.06.010","journal-title":"Gastroenterology"},{"key":"4541_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cld.2012.11.002","volume":"17","author":"ES Bjornsson","year":"2013","unstructured":"Bjornsson ES, Jonasson JG (2013) Drug-induced cholestasis. Clin Liver Dis 17:191\u2013209. https:\/\/doi.org\/10.1016\/j.cld.2012.11.002","journal-title":"Clin Liver Dis"},{"issue":"1","key":"4541_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92011-7","volume":"11","author":"M Boul","year":"2021","unstructured":"Boul M, Benzoubir N, Messina A, Ghasemi R, Ben Mosbah I, Duclos-Vall\u00e9e JC, Dubart-Kupperschmitt A, Le Pioufle B (2021) A versatile microfluidic tool for the 3D culture of HepaRG cells seeded at various stages of differentiation. Sci Rep 11(1):14075-. https:\/\/doi.org\/10.1038\/s41598-021-92011-7","journal-title":"Sci Rep"},{"key":"4541_CR30","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/cphy.c120027","volume":"3","author":"JL Boyer","year":"2013","unstructured":"Boyer JL (2013) Bile formation and secretion. Compr Physiol 3:1035. https:\/\/doi.org\/10.1002\/cphy.c120027","journal-title":"Compr Physiol"},{"key":"4541_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100561","volume":"4","author":"PR Braadland","year":"2022","unstructured":"Braadland PR, Schneider KM, Bergquist A, Molinaro A, L\u00f6vgren-Sandblom A, Henricsson M, Karlsen TH, Vesterhus M, Trautwein C, Hov JR, Marschall HU (2022) Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis. JHEP Rep 4:100561. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100561","journal-title":"JHEP Rep"},{"key":"4541_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109728","author":"T Brecklinghaus","year":"2022","unstructured":"Brecklinghaus T, Albrecht W, Kappenberg F, Duda J, Vartak N, Edlund K, Marchan R, Ghallab A, Cadenas C, G\u00fcnther G, Leist M, Zhang M, Gardner I, Reinders J, Russel FG, Foster AJ, Williams DP, Damle-Vartak A, Grandits M, Ecker G, Kittana N, Rahnenf\u00fchrer J, Hengstler JG (2022) The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds. Chem Biol Interact. https:\/\/doi.org\/10.1016\/j.cbi.2021.109728","journal-title":"Chem Biol Interact"},{"issue":"12","key":"4541_CR33","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarr\u00f3 LM, Bradshaw CR, Allen GE, Arnes-Benito R, Sidorova O, Gaspersz MP, Georgakopoulos N (2017) Human primary liver cancer\u2013derived organoid cultures for disease modeling and drug screening. Nat Med 23(12):1424\u20131435. https:\/\/doi.org\/10.1038\/nm.4438","journal-title":"Nat Med"},{"key":"4541_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/clpt.2013.81","volume":"94","author":"KLR Brouwer","year":"2013","unstructured":"Brouwer KLR, Keppler D, Hoffmaster KA, Bow DAJ, Cheng Y, Lai Y, Palm JE, Stieger B, Evers R (2013) In vitro methods to support transporter evaluation in drug discovery and development. Clin Pharmacol Ther 94:95\u2013112. https:\/\/doi.org\/10.1038\/clpt.2013.81","journal-title":"Clin Pharmacol Ther"},{"key":"4541_CR35","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1124\/dmd.116.071373","volume":"44","author":"MG Burbank","year":"2016","unstructured":"Burbank MG, Burban A, Sharanek A, Weaver RJ, Guguen-Guillouzo C, Guillouzo A (2016) Early alterations of bile canaliculi dynamics and the rho kinase\/myosin light chain kinase pathway are characteristics of drug-induced intrahepatic cholestasis. Sci Rep 44:1780\u20131793. https:\/\/doi.org\/10.1124\/dmd.116.071373","journal-title":"Sci Rep"},{"key":"4541_CR36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/toxsci\/kfx062","volume":"157","author":"MG Burbank","year":"2017","unstructured":"Burbank MG, Sharanek A, Burban A, Mialanne H, Aerts H, Guguen-Guillouzo C, Weaver RJ, Guillouzo A (2017) From the cover: mechanistic insights in cytotoxic and cholestatic potential of the endothelial receptor antagonists using HepaRG cells. Toxicol Sci 157:451\u2013464. https:\/\/doi.org\/10.1093\/toxsci\/kfx062","journal-title":"Toxicol Sci"},{"key":"4541_CR37","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1053\/gast.2002.36591","volume":"123","author":"JA Byrne","year":"2002","unstructured":"Byrne JA, Strautnieks SS, MieliVergani G, Higgins CF, Linton KJ, Thompson RJ (2002) The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastroenterology 123:1649\u20131658. https:\/\/doi.org\/10.1053\/gast.2002.36591","journal-title":"Gastroenterology"},{"key":"4541_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1517\/14728222.10.3.409","volume":"10","author":"SY Cai","year":"2006","unstructured":"Cai SY, Boyer JL (2006) FXR: a target for cholestatic syndromes? Expert Opin Ther Targets 10:409\u2013421. https:\/\/doi.org\/10.1517\/14728222.10.3.409","journal-title":"Expert Opin Ther Targets"},{"key":"4541_CR39","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1194\/jlr.M005546","volume":"51","author":"SY Cai","year":"2010","unstructured":"Cai SY, He H, Nguyen T, Mennone A, Boyer JL (2010) Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR\/RXR-dependent and independent mechanisms. J Lipid Res 51:2265. https:\/\/doi.org\/10.1194\/jlr.M005546","journal-title":"J Lipid Res"},{"key":"4541_CR40","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90780","author":"SY Cai","year":"2017","unstructured":"Cai SY, Ouyang X, Chen Y, Soroka CJ, Wang J, Mennone A, Wang Y, Mehal WZ, Jain D, Boyer JL (2017) Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.90780","journal-title":"JCI Insight"},{"key":"4541_CR41","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.2000.278.4.g522","author":"T Cantz","year":"2000","unstructured":"Cantz T, Nies AT, Brom M, Hofmann AF, Keppler D (2000) MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of HepG2 cells. Am J Physiol Gastrointest Liver Physiol. https:\/\/doi.org\/10.1152\/ajpgi.2000.278.4.g522","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4541_CR42","doi-asserted-by":"publisher","unstructured":"Y. \u00c7etin, Assessing the toxic potential of new entities: The role of cytotoxicity assays, (2025). https:\/\/doi.org\/10.5772\/intechopen.1008309","DOI":"10.5772\/intechopen.1008309"},{"key":"4541_CR43","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s11605-011-1473-2","volume":"15","author":"J Chai","year":"2011","unstructured":"Chai J, Luo D, Wu X, Wang H, He Y, Li Q, Zhang Y, Chen L, Peng ZH, Xiao T, Wang R, Chen W (2011) Changes of organic anion transporter MRP4 and related nuclear receptors in human obstructive cholestasis. J Gastrointest Surg 15:996\u20131004. https:\/\/doi.org\/10.1007\/s11605-011-1473-2","journal-title":"J Gastrointest Surg"},{"key":"4541_CR44","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1124\/dmd.114.057968","volume":"42","author":"JH Chang","year":"2014","unstructured":"Chang JH, Ly J, Plise E, Zhang X, Messick K, Wright M, Cheong J (2014) Differential effects of rifampin and ketoconazole on the blood and liver concentration of atorvastatin in wild-type and cyp3a and oatp1a\/b knockout mice. Drug Metab Dispos 42:1067\u20131073. https:\/\/doi.org\/10.1124\/dmd.114.057968","journal-title":"Drug Metab Dispos"},{"key":"4541_CR45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.taap.2013.10.032","volume":"274","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S, Richert L, Augustijns P, Annaert P (2014) Hepatocyte-based in vitro model for assessment of drug-induced cholestasis. Toxicol Appl Pharmacol 274:124\u2013136. https:\/\/doi.org\/10.1016\/j.taap.2013.10.032","journal-title":"Toxicol Appl Pharmacol"},{"key":"4541_CR46","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/J.1440-1746.1996.TB00095.X;PAGE:STRING:ARTICLE\/CHAPTER","volume":"11","author":"J Chen","year":"1996","unstructured":"Chen J, Farrell GC (1996) Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and ether hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis. J Gastroenterol Hepatol 11:870\u2013877. https:\/\/doi.org\/10.1111\/J.1440-1746.1996.TB00095.X;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"J Gastroenterol Hepatol"},{"key":"4541_CR47","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1203\/pdr.0b013e318170a6b5","volume":"63","author":"HL Chen","year":"2008","unstructured":"Chen HL, Liu YJ, Chen HL, Wu SH, Ni YH, Ho MC, Lai HS, Hsu WM, Hsu HY, Tseng HC, Jeng YM, Chang MH (2008) Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia. Pediatr Res 63:667\u2013673. https:\/\/doi.org\/10.1203\/pdr.0b013e318170a6b5","journal-title":"Pediatr Res"},{"key":"4541_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205175","volume":"13","author":"Y Chen","year":"2018","unstructured":"Chen Y, Yuan X, Xiao Z, Jin H, Zhang L, Liu Z (2018) Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening. PLoS ONE 13:e0205175. https:\/\/doi.org\/10.1371\/journal.pone.0205175","journal-title":"PLoS ONE"},{"key":"4541_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/J.BCP.2019.113669","author":"Y Chen","year":"2019","unstructured":"Chen Y, Zhou J, Xu S, Liu M, Wang M, Ma Y, Zhao M, Wang Z, Guo Y, Zhao L (2019) Association between the perturbation of bile acid homeostasis and valproic acid-induced hepatotoxicity. Biochem Pharmacol. https:\/\/doi.org\/10.1016\/J.BCP.2019.113669","journal-title":"Biochem Pharmacol"},{"key":"4541_CR50","doi-asserted-by":"publisher","first-page":"623","DOI":"10.14573\/altex.2002291","volume":"37","author":"Z Chen","year":"2020","unstructured":"Chen Z, Liu Y, Wright FA, Chiu WA, Rusyn I (2020) Rapid hazard characterization of environmental chemicals using a compendium of human cell lines from different organs. Altex 37:623\u2013638. https:\/\/doi.org\/10.14573\/altex.2002291","journal-title":"Altex"},{"key":"4541_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/TOXSCI\/KFN147","volume":"106","author":"X Cheng","year":"2008","unstructured":"Cheng X, Klaassen CD (2008) Perfluorocarboxylic acids induce cytochrome P450 enzymes in mouse liver through activation of PPAR-alpha and CAR transcription factors. Toxicol Sci 106:29\u201336. https:\/\/doi.org\/10.1093\/TOXSCI\/KFN147","journal-title":"Toxicol Sci"},{"key":"4541_CR52","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1194\/JLR.R900010-JLR200","volume":"50","author":"JYL Chiang","year":"2009","unstructured":"Chiang JYL (2009) Bile acids: regulation of synthesis. J Lipid Res 50:1955. https:\/\/doi.org\/10.1194\/JLR.R900010-JLR200","journal-title":"J Lipid Res"},{"key":"4541_CR53","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10545-011-9416-3","volume":"35","author":"CPK Chong","year":"2012","unstructured":"Chong CPK, Mills PB, McClean P, Gissen P, Bruce C, Stahlschmidt J, Knisely AS, Clayton PT (2012) Bile acid-CoA ligase deficiency- a new inborn error of bile acid metabolism. J Inherit Metab Dis 35:521\u2013530. https:\/\/doi.org\/10.1007\/s10545-011-9416-3","journal-title":"J Inherit Metab Dis"},{"key":"4541_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2020.104855","author":"RA Clewell","year":"2020","unstructured":"Clewell RA, Leonard JA, Nicolas CI, Campbell JL, Yoon M, Efremenko AY, McMullen PD, Andersen ME, Clewell HJ, Phillips KA, Tan YM (2020) Application of a combined aggregate exposure pathway and adverse outcome pathway (AEP-AOP) approach to inform a cumulative risk assessment: a case study with phthalates. Toxicol in Vitro. https:\/\/doi.org\/10.1016\/j.tiv.2020.104855","journal-title":"Toxicol in Vitro"},{"key":"4541_CR55","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ieam.4153","volume":"15","author":"K Coady","year":"2019","unstructured":"Coady K, Browne P, Embry M, Hill T, Leinala E, Steeger T, Ma\u015blankiewicz L, Hutchinson T (2019) When are adverse outcome pathways and associated assays \u201cfit for purpose\u201d for regulatory decision-making and management of chemicals? Integr Environ Assess Manag 15:633\u2013647. https:\/\/doi.org\/10.1002\/ieam.4153","journal-title":"Integr Environ Assess Manag"},{"key":"4541_CR56","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/00498254.2011.614021","volume":"42","author":"F Colombo","year":"2012","unstructured":"Colombo F, Armstrong C, Duan J, Rioux N (2012) A high throughput in vitro mrp2 assay to predict in vivo biliary excretion. Xenobiotica 42:157\u2013163. https:\/\/doi.org\/10.3109\/00498254.2011.614021","journal-title":"Xenobiotica"},{"key":"4541_CR57","unstructured":"European Commission, Roadmap towards phasing out animal testing for chemical safety assessments, (2026). https:\/\/single-market-economy.ec.europa.eu\/publications\/roadmap-towards-phasing-out-animal-testing-chemical-safety-assessments_en (Accessed August Apr 2026)."},{"key":"4541_CR58","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/FMED.2019.00265","volume":"6","author":"JL Corbett","year":"2019","unstructured":"Corbett JL, Duncan SA (2019) iPSC-derived hepatocytes as a platform for disease modeling and drug discovery. Front Med 6:265. https:\/\/doi.org\/10.3389\/FMED.2019.00265","journal-title":"Front Med"},{"key":"4541_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/507057","author":"J Corinaldi","year":"2012","unstructured":"Corinaldi J, Nasrallah R, Clark J, Paris G, Miura P, Jasmin BJ, H\u00e9bert RL (2012) Troglitazone induces extracellular matrix and cytoskeleton remodeling in mouse collecting duct cells. J Biomed Biotechnol. https:\/\/doi.org\/10.1155\/2012\/507057","journal-title":"J Biomed Biotechnol"},{"key":"4541_CR60","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1152\/Ajpgi.00508.2002","volume":"285","author":"FA Crocenzi","year":"2003","unstructured":"Crocenzi FA, Mottino AD, Cao J, Veggi LM, S\u00e1nchez Pozzi EJ, Vore M, Coleman R, Roma MG (2003) Estradiol-17\u03b2-D-glucuronide induces endocytic internalization of Bsep in rats. Am J Physiol Gastrointest Liver Physiol 285:449\u2013459. https:\/\/doi.org\/10.1152\/Ajpgi.00508.2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4541_CR61","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1124\/dmd.106.009308","volume":"34","author":"FA Crocenzi","year":"2006","unstructured":"Crocenzi FA, Pellegrino JM, Catania VA, Luquita MG, Roma MG, Mottino AD, \u015aanchezPozzi EJ (2006) Galactosamine prevents ethinylestradiol-induced cholestasis, Drug Metab. Dispos. 34:993\u2013997. https:\/\/doi.org\/10.1124\/dmd.106.009308","journal-title":"Dispos."},{"key":"4541_CR62","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.2741\/3981","volume":"17","author":"FA Crocenzi","year":"2012","unstructured":"Crocenzi FA, Zucchetti AE, Boaglio AC, Barosso IR, Sanchez Pozzi EJ, Mottino AD, Roma MG (2012) Localization status of hepatocellular transporters in cholestasis. Front Biosci 17:1201\u20131218. https:\/\/doi.org\/10.2741\/3981","journal-title":"Front Biosci"},{"key":"4541_CR63","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2217\/pgs.10.37","volume":"11","author":"Y Cui","year":"2010","unstructured":"Cui Y, Paules RS (2010) Use of transcriptomics in understanding mechanisms of drug-induced toxicity. Pharmacogenomics 11:573\u2013585. https:\/\/doi.org\/10.2217\/pgs.10.37","journal-title":"Pharmacogenomics"},{"key":"4541_CR64","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1124\/mol.60.5.934","volume":"60","author":"Y Cui","year":"2001","unstructured":"Cui Y, K\u00f6nig J, Keppler D (2001) Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol Pharmacol 60:934\u2013943. https:\/\/doi.org\/10.1124\/mol.60.5.934","journal-title":"Mol Pharmacol"},{"key":"4541_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.114666","author":"M Cuykx","year":"2019","unstructured":"Cuykx M, Beirnaert C, Rodrigues RM, Laukens K, Vanhaecke T, Covaci A (2019) Untargeted liquid chromatography-mass spectrometry metabolomics to assess drug-induced cholestatic features in HepaRG\u00ae cells. Toxicol Appl Pharmacol. https:\/\/doi.org\/10.1016\/j.taap.2019.114666","journal-title":"Toxicol Appl Pharmacol"},{"key":"4541_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10070462","volume":"10","author":"E Danese","year":"2020","unstructured":"Danese E, Negrini D, Pucci M, De Nitto S, Ambrogi D, Donzelli S, Lievens PMJ, Salvagno GL, Lippi G (2020) Bile acids quantification by liquid chromatography\u2013tandem mass spectrometry: method validation, reference range, and interference study. Diagnostics 10:462. https:\/\/doi.org\/10.3390\/diagnostics10070462","journal-title":"Diagnostics"},{"key":"4541_CR67","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/bjd.15896","volume":"178","author":"B Dasgeb","year":"2018","unstructured":"Dasgeb B, Kornreich D, McGuinn K, Okon L, Brownell I, Sackett DL (2018) Colchicine: an ancient drug with novel applications. Br J Dermatol 178:350\u2013356. https:\/\/doi.org\/10.1111\/bjd.15896","journal-title":"Br J Dermatol"},{"key":"4541_CR68","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/B978-012088394-3\/50059-3","volume-title":"Phys. gastrointest. tract","author":"PA Dawson","year":"2006","unstructured":"Dawson PA, Shneider BL, Hofmann AF (2006) Bile formation and the enterohepatic circulation. Phys. gastrointest. tract. Elsevier, pp 1437\u20131462. https:\/\/doi.org\/10.1016\/B978-012088394-3\/50059-3"},{"key":"4541_CR69","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1124\/dmd.111.040758","volume":"40","author":"S Dawson","year":"2012","unstructured":"Dawson S, Stahl S, Paul N, Barber J, Kenna JG (2012) In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug Metab Dispos 40:130\u2013138. https:\/\/doi.org\/10.1124\/dmd.111.040758","journal-title":"Drug Metab Dispos"},{"key":"4541_CR70","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1007\/s00204-024-03775-6","volume":"98","author":"VMP de Bruijn","year":"2024","unstructured":"de Bruijn VMP, Rietjens IMCM (2024) From hazard to risk prioritization: a case study to predict drug-induced cholestasis using physiologically based kinetic modeling. Arch Toxicol 98:3077\u20133095. https:\/\/doi.org\/10.1007\/s00204-024-03775-6","journal-title":"Arch Toxicol"},{"key":"4541_CR71","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.toxlet.2022.06.004","volume":"365","author":"VMP de Bruijn","year":"2022","unstructured":"de Bruijn VMP, Wang Z, Bakker W, Zheng W, Spee B, Bouwmeester H (2022a) Hepatic bile acid synthesis and secretion: comparison of in vitro methods. Toxicol Lett 365:46\u201360. https:\/\/doi.org\/10.1016\/j.toxlet.2022.06.004","journal-title":"Toxicol Lett"},{"key":"4541_CR72","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1007\/s00204-022-03345-8","volume":"96","author":"VMP de Bruijn","year":"2022","unstructured":"de Bruijn VMP, Rietjens IMCM, Bouwmeester H (2022b) Population pharmacokinetic model to generate mechanistic insights in bile acid homeostasis and drug-induced cholestasis. Arch Toxicol 96:2717\u20132730. https:\/\/doi.org\/10.1007\/s00204-022-03345-8","journal-title":"Arch Toxicol"},{"key":"4541_CR73","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1002\/jps.22694","volume":"100","author":"T De Bruyn","year":"2011","unstructured":"De Bruyn T, Fattah S, Stieger B, Augustijns P, Annaert P (2011) Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3. J Pharm Sci 100:5018\u20135030. https:\/\/doi.org\/10.1002\/jps.22694","journal-title":"J Pharm Sci"},{"key":"4541_CR74","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1002\/jps.23933","volume":"103","author":"T De Bruyn","year":"2014","unstructured":"De Bruyn T, Sempels W, Snoeys J, Holmstock N, Chatterjee S, Stieger B, Augustijns P, Hofkens J, Mizuno H, Annaert P (2014) Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate disposition. J Pharm Sci 103:1872\u20131881. https:\/\/doi.org\/10.1002\/jps.23933","journal-title":"J Pharm Sci"},{"key":"4541_CR75","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jhep.2010.07.047","volume":"54","author":"W De Graaf","year":"2011","unstructured":"De Graaf W, H\u00e4usler S, Heger M, Van Ginhoven TM, Van Cappellen G, Bennink RJ, Kullak-Ublick GA, Hesselmann R, Van Gulik TM, Stieger B (2011) Transporters involved in the hepatic uptake of 99mTc-mebrofenin and indocyanine green. J Hepatol 54:738\u2013745. https:\/\/doi.org\/10.1016\/j.jhep.2010.07.047","journal-title":"J Hepatol"},{"key":"4541_CR76","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/PNAS.95.1.282","volume":"95","author":"JML De Vree","year":"1998","unstructured":"De Vree JML, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J, Deleuze JF, Desrochers M, Burdelski M, Bernard O, Oude Elferink RPJ, Hadchouel M (1998) Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A 95:282. https:\/\/doi.org\/10.1073\/PNAS.95.1.282","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4541_CR77","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1124\/jpet.110.166991","volume":"334","author":"DR De Waart","year":"2010","unstructured":"De Waart DR, H\u00e4usler S, Vlaming MLH, Kunne C, H\u00e4nggi E, Gruss HJ, Oude Elferink RPJ, Stieger B (2010) Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein. J Pharmacol Exp Ther 334:78\u201386. https:\/\/doi.org\/10.1124\/jpet.110.166991","journal-title":"J Pharmacol Exp Ther"},{"key":"4541_CR78","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0378-4274(92)90156-E","volume":"61","author":"NM Delzenne","year":"1992","unstructured":"Delzenne NM, Calderon PB, Taper HS, Roberfroid MB (1992) Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: in vivo and in vitro studies. Toxicol Lett 61:291\u2013304. https:\/\/doi.org\/10.1016\/0378-4274(92)90156-E","journal-title":"Toxicol Lett"},{"key":"4541_CR79","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1124\/jpet.105.097758","volume":"317","author":"R Deng","year":"2006","unstructured":"Deng R, Yang D, Yang J, Yan B (2006) Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor. J Pharmacol Exp Ther 317:317\u2013325. https:\/\/doi.org\/10.1124\/jpet.105.097758","journal-title":"J Pharmacol Exp Ther"},{"key":"4541_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1335836","volume":"15","author":"Q Deng","year":"2024","unstructured":"Deng Q, Yang Y, Liu Y, Zou M, Huang G, Yang S, Li L, Qu Y, Luo Y, Zhang X (2024) Assessing immune hepatotoxicity of troglitazone with a versatile liver-immune-microphysiological-system. Front Pharmacol 15:1335836. https:\/\/doi.org\/10.3389\/fphar.2024.1335836","journal-title":"Front Pharmacol"},{"key":"4541_CR81","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000297544","volume":"82","author":"GU Denk","year":"2010","unstructured":"Denk GU, Wimmer R, Vennegeerts T, Pusl T, Thasler W, Rust C (2010) Glycochenodeoxycholate-induced apoptosis is not reduced by augmenter of liver regeneration in the human hepatoma cell line HuH-7. Digestion 82:262\u2013264. https:\/\/doi.org\/10.1159\/000297544","journal-title":"Digestion"},{"key":"4541_CR82","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/gast.2001.25503","volume":"121","author":"LA Denson","year":"2001","unstructured":"Denson LA, Sturm E, Echevarria W, Zimmerman TL, Makishima M, Mangelsdorf DJ, Karpen SJ (2001) The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121:140\u2013147. https:\/\/doi.org\/10.1053\/gast.2001.25503","journal-title":"Gastroenterology"},{"key":"4541_CR83","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-4939-9420-5_2","volume":"2019","author":"D Dewaele","year":"1981","unstructured":"Dewaele D, Annaert P, Hoeben E (1981) LC-MS\/MS analysis of bile acids in in vitro samples. Methods Mol Biol 2019:15\u201323. https:\/\/doi.org\/10.1007\/978-1-4939-9420-5_2","journal-title":"Methods Mol Biol"},{"key":"4541_CR84","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1177\/0394632016672218;CTYPE:STRING:JOURNAL","volume":"29","author":"Y Ding","year":"2016","unstructured":"Ding Y, Xiong XL, Zhou LS, Yan SQ, Qin H, Li HR, Zhang LL, Chen P, Yao C, Jiang ZX, Zhao L (2016) Preliminary study on Emodin alleviating alpha-naphthylisothiocyanate-induced intrahepatic cholestasis by regulation of liver farnesoid X receptor pathway. Int J Immunopathol Pharmacol 29:805\u2013811. https:\/\/doi.org\/10.1177\/0394632016672218;CTYPE:STRING:JOURNAL","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4541_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2025.154372","volume":"520","author":"JL Domingo","year":"2026","unstructured":"Domingo JL (2026) Mixture toxicity revisited: a translational review of experimental evidence from animal models to human health risk assessment. Toxicology 520:154372. https:\/\/doi.org\/10.1016\/j.tox.2025.154372","journal-title":"Toxicology"},{"key":"4541_CR86","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1021\/mp300453k","volume":"10","author":"Z Dong","year":"2013","unstructured":"Dong Z, Ekins S, Polli JE (2013) Structure activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate co-transporting polypeptide (NTCP). Mol Pharm 10:1008. https:\/\/doi.org\/10.1021\/mp300453k","journal-title":"Mol Pharm"},{"key":"4541_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2025.154119","volume":"514","author":"A Drees","year":"2025","unstructured":"Drees A, Nassiri V, Tabernilla A, Serroyen J, Gustin E, dos Santos Rodrigues B, Moss DM, De Smedt A, Vinken M, Van Goethem F, Sanz-Serrano J (2025) Optimization of the drug-induced cholestasis index based on advanced modeling for predicting liver toxicity. Toxicology 514:154119. https:\/\/doi.org\/10.1016\/j.tox.2025.154119","journal-title":"Toxicology"},{"key":"4541_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2026.154547","volume":"526","author":"A Drees","year":"2026","unstructured":"Drees A, Benfenati E, Gadaleta D, Gozalbes R, Garcia de Lomana M, Jiang J, Maerten A, Ortega-Vallbona R, Serrano-Candelas E, Sanz-Serrano J, Vinken M (2026) Integrated in vitro\/in silico test battery for the prediction of chemical-induced cholestatic liver toxicity. Toxicology 526:154547. https:\/\/doi.org\/10.1016\/j.tox.2026.154547","journal-title":"Toxicology"},{"key":"4541_CR89","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/AD0261","volume":"16","author":"Y Du","year":"2023","unstructured":"Du Y, de Jong IEM, Gupta K, Waisbourd-Zinman O, Har-Zahav A, Soroka CJ, Boyer JL, Llewellyn J, Liu C, Naji A, Polacheck WJ, Wells RG (2023) Human vascularized bile duct-on-a chip: a multi-cellular micro-physiological system for studying cholestatic liver disease. Biofabrication 16:015004. https:\/\/doi.org\/10.1088\/1758-5090\/AD0261","journal-title":"Biofabrication"},{"key":"4541_CR90","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0016-5085(80)90239-5","volume":"79","author":"M Dubin","year":"1980","unstructured":"Dubin M, Maurice M, Feldmann G, Erlinger S (1980) Influence of colchicine and phalloidin on bile secretion and hepatic ultrastructure in the rat: possible interaction between microtubules and microfilaments. Gastroenterology 79:646\u2013654. https:\/\/doi.org\/10.1016\/0016-5085(80)90239-5","journal-title":"Gastroenterology"},{"key":"4541_CR91","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1007\/s00216-019-01890-3","volume":"411","author":"M Dutta","year":"2019","unstructured":"Dutta M, Cai J, Gui W, Patterson AD (2019) A review of analytical platforms for accurate bile acid measurement. Anal Bioanal Chem 411:4541\u20134549. https:\/\/doi.org\/10.1007\/s00216-019-01890-3","journal-title":"Anal Bioanal Chem"},{"key":"4541_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101531","volume":"26","author":"L Duwe","year":"2022","unstructured":"Duwe L, Fouassier L, Lafuente-Barquero J, Andersen JB (2022) Unraveling the actin cytoskeleton in the malignant transformation of cholangiocyte biology. Transl Oncol 26:101531. https:\/\/doi.org\/10.1016\/j.tranon.2022.101531","journal-title":"Transl Oncol"},{"key":"4541_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-026-02476-x","author":"AL Eadie","year":"2026","unstructured":"Eadie AL, Lynch HF, Scheinerman N, Parikh RB (2026) Advancing FDA new approach methodologies from animal models through digital twins. NPJ Digit Med. https:\/\/doi.org\/10.1038\/s41746-026-02476-x","journal-title":"NPJ Digit Med"},{"key":"4541_CR94","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3748\/wjg.v6.i4.522","volume":"6","author":"C Einarsson","year":"2000","unstructured":"Einarsson C, Ellis E, Abrahamson A, Ericzon BG, Bjorkhem I, Axelson M (2000) Bile acid formation in primary human hepatocytes. World J Gastroenterol 6:522. https:\/\/doi.org\/10.3748\/wjg.v6.i4.522","journal-title":"World J Gastroenterol"},{"key":"4541_CR95","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jhep.2010.01.010","volume":"52","author":"TJ Erichsen","year":"2010","unstructured":"Erichsen TJ, Aehlen A, Ehmer U, Kalthoff S, Manns MP, Strassburg CP (2010) Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids. J Hepatol 52:570\u2013578. https:\/\/doi.org\/10.1016\/j.jhep.2010.01.010","journal-title":"J Hepatol"},{"key":"4541_CR96","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1194\/jlr.M040519","volume":"54","author":"ZZ Fang","year":"2013","unstructured":"Fang ZZ, He RR, Cao YF, Tanaka N, Jiang C, Krausz KW, Qi Y, Dong PP, Ai CZ, Sun XY, Hong M, Ge GB, Gonzalez FJ, Ma XC, Sun HZ (2013) A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders. J Lipid Res 54:3334\u20133344. https:\/\/doi.org\/10.1194\/jlr.M040519","journal-title":"J Lipid Res"},{"key":"4541_CR97","doi-asserted-by":"publisher","first-page":"29745","DOI":"10.1074\/jbc.273.45.29745","volume":"273","author":"AS Fanning","year":"1998","unstructured":"Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM (1998) The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 273:29745\u201329753. https:\/\/doi.org\/10.1074\/jbc.273.45.29745","journal-title":"J Biol Chem"},{"key":"4541_CR98","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1067\/mcp.2001.114667","volume":"69","author":"K Fattinger","year":"2001","unstructured":"Fattinger K (2001) The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions. Clin Pharmacol Ther 69:223\u2013231. https:\/\/doi.org\/10.1067\/mcp.2001.114667","journal-title":"Clin Pharmacol Ther"},{"key":"4541_CR99","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0002-9440(10)64868-7","volume":"160","author":"P Fickert","year":"2002","unstructured":"Fickert P, Trauner M, Fuchsbichler A, Stumptner C, Zatloukal K, Denk H (2002) Cytokeratins as targets for bile acid-induced toxicity. Am J Pathol 160:491\u2013499. https:\/\/doi.org\/10.1016\/S0002-9440(10)64868-7","journal-title":"Am J Pathol"},{"key":"4541_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/S41575-021-00566-7","author":"CD Fuchs","year":"2022","unstructured":"Fuchs CD, Trauner M (2022) Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat Rev Gastroenterol Hepatol. https:\/\/doi.org\/10.1038\/S41575-021-00566-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4541_CR101","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1124\/dmd.110.033258","volume":"38","author":"H Fukuda","year":"2010","unstructured":"Fukuda H, Ohashi R, Ohashi N, Yabuuchi H, Tamai I (2010) Estimation of transporters involved in the hepatobiliary transport of TA-0201CA using sandwich-cultured rat hepatocytes from normal and multidrug resistance-associated protein 2-deficient rats. Drug Metab Dispos 38:1505\u20131513. https:\/\/doi.org\/10.1124\/dmd.110.033258","journal-title":"Drug Metab Dispos"},{"key":"4541_CR102","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0928-4346(96)00329-5","volume":"6","author":"Y Fukumoto","year":"1996","unstructured":"Fukumoto Y, Hino K, Yasunaga M, Okita K (1996) Changes of depolymerized and polymerized tubulin proteins in the liver after taurocholic acid administration with or without colchicine pretreatment and cholestasis due to cytochalasin B and bile duct ligation in rats. Int Hepatol Commun 6:49\u201355. https:\/\/doi.org\/10.1016\/S0928-4346(96)00329-5","journal-title":"Int Hepatol Commun"},{"key":"4541_CR103","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/hep.1840120307","volume":"12","author":"PR Galle","year":"1990","unstructured":"Galle PR, Theilmann L, Raedsch R, Otto G, Stiehl A (1990) Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 12:486\u2013491. https:\/\/doi.org\/10.1002\/hep.1840120307","journal-title":"Hepatology"},{"key":"4541_CR104","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1194\/jlr.D028803","volume":"53","author":"JC Garc\u00eda-Ca\u00f1averas","year":"2012","unstructured":"Garc\u00eda-Ca\u00f1averas JC, Donato MT, Castell JV, Lahoz A (2012) Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method. J Lipid Res 53:2231\u20132241. https:\/\/doi.org\/10.1194\/jlr.D028803","journal-title":"J Lipid Res"},{"key":"4541_CR105","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1124\/dmd.113.054189","volume":"42","author":"B Garzel","year":"2014","unstructured":"Garzel B, Yang H, Zhang L, Huang S-M, Polli JE, Wang H (2014) The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity. Drug Metab Dispos 42:318\u2013322. https:\/\/doi.org\/10.1124\/dmd.113.054189","journal-title":"Drug Metab Dispos"},{"key":"4541_CR106","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1039\/c6tx00101g","volume":"5","author":"H Gaskell","year":"2016","unstructured":"Gaskell H, Sharma P, Colley HE, Murdoch C, Williams DP, Webb SD (2016) Characterization of a functional C3A liver spheroid model. Toxicol Res 5:1053\u20131065. https:\/\/doi.org\/10.1039\/c6tx00101g","journal-title":"Toxicol Res"},{"key":"4541_CR107","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1105\/tpc.11.12.2349","volume":"11","author":"BC Gibbon","year":"1999","unstructured":"Gibbon BC, Kovar DR, Staiger CJ (1999) Latrunculin B has different effects on pollen germination and tube growth. Plant Cell 11:2349\u20132363. https:\/\/doi.org\/10.1105\/tpc.11.12.2349","journal-title":"Plant Cell"},{"key":"4541_CR108","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/AIVT.2017.0027","volume":"3","author":"E Gijbels","year":"2017","unstructured":"Gijbels E, Vinken M (2017) An update on adverse outcome pathways leading to liver injury. Appl in Vitro Toxicol 3:283\u2013285. https:\/\/doi.org\/10.1089\/AIVT.2017.0027","journal-title":"Appl in Vitro Toxicol"},{"key":"4541_CR109","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/S00204-019-02437-2","volume":"93","author":"E Gijbels","year":"2019","unstructured":"Gijbels E, Vilas-Boas V, Deferm N, Devisscher L, Jaeschke H, Annaert P, Vinken M (2019) Mechanisms and in vitro models of drug-induced cholestasis. Arch Toxicol 93:1169\u20131186. https:\/\/doi.org\/10.1007\/S00204-019-02437-2","journal-title":"Arch Toxicol"},{"key":"4541_CR110","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00204-020-02691-9","volume":"94","author":"E Gijbels","year":"2020","unstructured":"Gijbels E, Vilas-Boas V, Annaert P, Vanhaecke T, Devisscher L, Vinken M (2020a) Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol 94:1151\u20131172. https:\/\/doi.org\/10.1007\/s00204-020-02691-9","journal-title":"Arch Toxicol"},{"key":"4541_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2020.106156","author":"E Gijbels","year":"2020","unstructured":"Gijbels E, Devisscher L, Vinken M (2020b) Dataset on transcriptomic profiling of cholestatic liver injury in an in vitro and in vivo animal model. Data Brief. https:\/\/doi.org\/10.1016\/j.dib.2020.106156","journal-title":"Data Brief"},{"key":"4541_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2021.112165","author":"E Gijbels","year":"2021","unstructured":"Gijbels E, Devisscher L, Vinken M (2021a) Testing in vitro tools for the prediction of cholestatic liver injury induced by non-pharmaceutical chemicals. Food Chem Toxicol. https:\/\/doi.org\/10.1016\/j.fct.2021.112165","journal-title":"Food Chem Toxicol"},{"key":"4541_CR113","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/LIV.14800","volume":"41","author":"E Gijbels","year":"2021","unstructured":"Gijbels E, Pieters A, De Muynck K, Vinken M, Devisscher L (2021b) Rodent models of cholestatic liver disease: a practical guide for translational research. Liver Int 41:656\u2013682. https:\/\/doi.org\/10.1111\/LIV.14800","journal-title":"Liver Int"},{"key":"4541_CR114","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1124\/dmd.116.074740","volume":"45","author":"RR Gilibili","year":"2017","unstructured":"Gilibili RR, Chatterjee S, Bagul P, Mosure KW, Murali BV, Mariappan TT, Mandlekar S, Lai Y (2017) Coproporphyrin-I: a fluorescent, endogenous optimal probe substrate for ABCC2 (MRP2) suitable for vesicle-based MRP2 inhibition assay. Drug Metab Dispos 45:604\u2013611. https:\/\/doi.org\/10.1124\/dmd.116.074740","journal-title":"Drug Metab Dispos"},{"key":"4541_CR115","doi-asserted-by":"publisher","first-page":"44","DOI":"10.12998\/WJCC.V6.I4.44","volume":"6","author":"M Girardin","year":"2014","unstructured":"Girardin M, Hadengue A, Frossard JL, Anderegg C, Bauerfeind P, Beglinger C, Begr\u00e9 S, Belli D, Bengoa JM, Biedermann L, Bigler B, Binek J, Blattmann M, Boehm S, Borovicka J, Braegger CP, Brunner N, B\u00fchr P, Burnand B, Burri E, Buyse S, Cremer M, Criblez DH, de Saussure P, Degen L, Delarive J, Doerig C, Dora B, Dorta G, Egger M, Ehmann T, El-Wafa A, Engelmann M, Ezri J, Felley C, Fliegner M, Fournier N, Fraga M, Frei P, Frei R, Fried M, Froehlich F, Funk C, Furlano RI, Gallot-Lavall\u00e9e S, Geyer M, Golay D, Grandinetti T, Gysi B, Haack H, Haarer J, Helbling B, Hengstler P, Herzog D, Hess C, Heyland K, Hinterleitner T, Hiroz P, Hirschi C, Hruz P, Iwata R, Jost R, Juillerat P, Brondolo VK, Knellwolf C, Knoblauch C, K\u00f6hler H, Koller R, Krieger-Gr\u00fcbel C, Kullak-Ublick G, K\u00fcnzler P, Landolt M, Lange R, Lehmann FS, Macpherson A, Maerten P, Maillard MH, Manser C, Manz M, Marbet U, Marx G, Matter C, McLin V, Meier R, Mendanova M, Meyenberger C, Michetti P, Misselwitz B, Moradpour D, Morell B, Mosler P, Mottet C, M\u00fcller C, M\u00fcller P, M\u00fcllhaupt B, M\u00fcnger-Beyeler C, Musso L, Nagy A, Neagu M, Nichita C, Niess J, No\u00ebl N, Nydegger A, Obialo N, Oneta C, Oropesa C, Peter U, Peternac D, Petit LM, Piccoli-Gfeller F, Pilz JB, Pittet V, Raschle N, Rentsch R, Restellini S, Richterich JP, Rihs S, Ritz MA, Roduit J, Rogler D, Rogler G, Rossel JB, Sagmeister M, Saner G, Sauter B, Sawatzki M, Sch\u00e4ppi M, Scharl M, Schelling M, Schibli S, Schlauri H, Uebelhart SS, Schnegg JF, Schoepfer A, Seibold F, Seirafi M, Semadeni GM, Semela D, Senning A, Sidler M, Sokollik C, Spalinger J, Spangenberger H, Stadler P, Steuerwald M, Straumann A, Straumann-Funk B, Sulz M, Thorens J, Tiedemann S, Tutuian R, Vavricka S, Viani F, V\u00f6gtlin J, Von K\u00e4nel R, Vonlaufen A, Vouillamoz D, Vulliamy R, Wermuth J, Werner H, Wiesel P, Wiest R, Wylie T, Zeitz J, Zimmermann D (2014) High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients. World J. Clin. Cases 6:44\u201353. https:\/\/doi.org\/10.12998\/WJCC.V6.I4.44","journal-title":"World J. Clin. Cases"},{"key":"4541_CR116","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jhep.2015.06.015","volume":"63","author":"P Gissen","year":"2015","unstructured":"Gissen P, Arias IM (2015) Structural and functional hepatocyte polarity and liver disease. J Hepatol 63:1023. https:\/\/doi.org\/10.1016\/j.jhep.2015.06.015","journal-title":"J Hepatol"},{"key":"4541_CR117","unstructured":"OECD (Organisation for Economic Co-operation and Development), Guidance document on good in vitro method practices (GIVIMP), 2018."},{"key":"4541_CR118","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00008571-200410000-00001","volume":"14","author":"C Gnerre","year":"2004","unstructured":"Gnerre C, Bl\u00e4ttler S, Kaufmann MR, Looser R, Meyer UA (2004) Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene. Pharmacogenetics 14:635\u2013645. https:\/\/doi.org\/10.1097\/00008571-200410000-00001","journal-title":"Pharmacogenetics"},{"key":"4541_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/metabo10070282","volume":"10","author":"C G\u00f3mez","year":"2020","unstructured":"G\u00f3mez C, St\u00fccheli S, Kratschmar DV, Bouitbir J, Odermatt A (2020) Development and validation of a highly sensitive LC-MS\/MS method for the analysis of bile acids in serum, plasma, and liver tissue samples. Metabolites 10:1\u201317. https:\/\/doi.org\/10.3390\/metabo10070282","journal-title":"Metabolites"},{"key":"4541_CR120","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.tiv.2010.07.018","volume":"24","author":"MJ G\u00f3mez-Lech\u00f3n","year":"2010","unstructured":"G\u00f3mez-Lech\u00f3n MJ, Tolosa L, Castell JV, Donato MT (2010) Mechanism-based selection of compounds for the development of innovative in vitro approaches to hepatotoxicity studies in the LIINTOP project. Toxicol in Vitro 24:1879\u20131889. https:\/\/doi.org\/10.1016\/j.tiv.2010.07.018","journal-title":"Toxicol in Vitro"},{"key":"4541_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/ANNUREV.PHARMTOX.42.111901.111051","volume":"42","author":"B Goodwin","year":"2002","unstructured":"Goodwin B, Redinbo MR, Kliewer SA (2002) Regulation of cyp3a gene transcription by the pregnane x receptor. Annu Rev Pharmacol Toxicol 42:1\u201323. https:\/\/doi.org\/10.1146\/ANNUREV.PHARMTOX.42.111901.111051","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4541_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1528748","volume":"16","author":"K Graf","year":"2025","unstructured":"Graf K, Murrieta-Coxca JM, Vogt T, Besser S, Geilen D, Kaden T, Bothe AK, Morales-Prieto DM, Amiri B, Schaller S, Kaufmann L, Raasch M, Ammar RM, Maass C (2025) Digital twin-enhanced three-organ microphysiological system for studying drug pharmacokinetics in pregnant women. Front Pharmacol 16:1528748. https:\/\/doi.org\/10.3389\/fphar.2025.1528748","journal-title":"Front Pharmacol"},{"key":"4541_CR123","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.3390\/IJMS25073684\/S1","volume":"25","author":"L Guerrero","year":"2024","unstructured":"Guerrero L, Vindel-Alfageme J, Hierro L, Stark L, Vicent D, Sorzano C\u00d3S, Corrales FJ (2024) Discrimination of etiologically different cholestasis by modeling proteomics datasets. Int J Mol Sci 25:3684. https:\/\/doi.org\/10.3390\/IJMS25073684\/S1","journal-title":"Int J Mol Sci"},{"key":"4541_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1875397301004010001","volume":"4","author":"C Gui","year":"2010","unstructured":"Gui C, Obaidat A, Chaguturu R, Hagenbuch B (2010) Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3. Curr Chem Genomics 4:1. https:\/\/doi.org\/10.2174\/1875397301004010001","journal-title":"Curr Chem Genomics"},{"key":"4541_CR125","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/toxsci\/kft021","volume":"133","author":"P Gunness","year":"2013","unstructured":"Gunness P, Mueller D, Shevchenko V, Heinzle E, Ingelman-Sundberg M, Noor F (2013) 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies. Toxicol Sci 133:67\u201378. https:\/\/doi.org\/10.1093\/toxsci\/kft021","journal-title":"Toxicol Sci"},{"key":"4541_CR126","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3109\/15376516.2015.1033074","volume":"25","author":"YX Guo","year":"2015","unstructured":"Guo YX, Xu XF, Zhang QZ, Li C, Deng Y, Jiang P, He LY, Peng WX (2015) The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid\/rifampicin-induced hepatotoxicity. Toxicol Mech Methods 25:382\u2013387. https:\/\/doi.org\/10.3109\/15376516.2015.1033074","journal-title":"Toxicol Mech Methods"},{"key":"4541_CR127","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/J.JHEP.2017.01.026","volume":"66","author":"K Gupta","year":"2017","unstructured":"Gupta K, Li Q, Fan JJ, Fong ELS, Song Z, Mo S, Tang H, Ng IC, Ng CW, Pawijit P, Zhuo S, Dong CY, Low BC, Wee A, Dan YY, Kanchanawong P, So P, Viasnoff V, Yu H (2017) Actomyosin contractility drives bile regurgitation as an early response during obstructive cholestasis. J Hepatol 66:1231\u20131240. https:\/\/doi.org\/10.1016\/J.JHEP.2017.01.026","journal-title":"J Hepatol"},{"key":"4541_CR128","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1124\/dmd.120.000086","volume":"48","author":"MJ Hafey","year":"2020","unstructured":"Hafey MJ, Houle R, Tanis KQ, Knemeyer I, Shang J, Chen Q, Baudy A, Monroe J, Sistare FD, Evers R (2020) A two-tiered in vitro approach to de-risk drug candidates for potential bile salt export pump inhibition liabilities in drug discovery. Drug Metab Dispos 48:1147\u20131160. https:\/\/doi.org\/10.1124\/dmd.120.000086","journal-title":"Drug Metab Dispos"},{"key":"4541_CR129","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cld.2012.12.001","volume":"17","author":"E Halilbasic","year":"2013","unstructured":"Halilbasic E, Baghdasaryan A, Trauner M (2013) Nuclear receptors as drug targets in cholestatic liver diseases. Clin Liver Dis 17:161. https:\/\/doi.org\/10.1016\/j.cld.2012.12.001","journal-title":"Clin Liver Dis"},{"key":"4541_CR130","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ab.2006.04.046","volume":"356","author":"M Hampf","year":"2006","unstructured":"Hampf M, Gossen M (2006) A protocol for combined Photinus and Renilla luciferase quantification compatible with protein assays. Anal Biochem 356:94\u201399. https:\/\/doi.org\/10.1016\/j.ab.2006.04.046","journal-title":"Anal Biochem"},{"key":"4541_CR131","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1124\/DMD.108.025155","volume":"37","author":"S Han","year":"2008","unstructured":"Han S, Chiang JYL (2008) Mechanism of vitamin D receptor inhibition of cholesterol 7\u03b1-hydroxylase gene transcription in human hepatocytes. Drug Metab Dispos 37:469. https:\/\/doi.org\/10.1124\/DMD.108.025155","journal-title":"Drug Metab Dispos"},{"key":"4541_CR132","doi-asserted-by":"publisher","DOI":"10.25259\/jksus_222_2024","author":"A Haque","year":"2025","unstructured":"Haque A, Baig GA, Alshawli AS, Alharthi M, Naseer MI, Pushparaj PN, Rasool M, Opo FADM, Haque A, Baig GA, Alshawli AS, Alharthi M, Naseer MI, Pushparaj PN, Rasool M, Opo FADM (2025) Evaluation of potential substrates and inhibitors of MRP2 transporter to predict effective combinatorial chemotherapeutic agents for treating MRP2-associated non-responsive colorectal cancer. J King Saud Univ Sci. https:\/\/doi.org\/10.25259\/jksus_222_2024","journal-title":"J King Saud Univ Sci"},{"key":"4541_CR133","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/NAR\/GKN1047","volume":"37","author":"N Hariparsad","year":"2009","unstructured":"Hariparsad N, Chu X, Yabut J, Labhart P, Hartley DP, Dai X, Evers R (2009) Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes. Nucleic Acids Res 37:1160. https:\/\/doi.org\/10.1093\/NAR\/GKN1047","journal-title":"Nucleic Acids Res"},{"key":"4541_CR134","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1124\/dmd.109.031831","volume":"38","author":"SN Hart","year":"2010","unstructured":"Hart SN, Li Y, Nakamoto K, Subileau EA, Steen D, Zhong XB (2010) A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues. Drug Metab Dispos 38:988\u2013994. https:\/\/doi.org\/10.1124\/dmd.109.031831","journal-title":"Drug Metab Dispos"},{"key":"4541_CR135","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1139\/Y10-060","volume":"88","author":"JC Hartman","year":"2010","unstructured":"Hartman JC, Brouwer K, Mandagere A, Melvin L, Gorczynski R (2010) Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes. Can J Physiol Pharmacol 88:682\u2013691. https:\/\/doi.org\/10.1139\/Y10-060","journal-title":"Can J Physiol Pharmacol"},{"key":"4541_CR136","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.stemcr.2020.12.008","volume":"16","author":"H Hayashi","year":"2021","unstructured":"Hayashi H, Osaka S, Sakabe K, Fukami A, Kishimoto E, Aihara E, Sabu Y, Mizutani A, Kusuhara H, Naritaka N, Zhang W, Huppert SS, Sakabe M, Nakamura T, Hu YC, Mayhew C, Setchell K, Takebe T, Asai A (2021) Modeling human bile acid transport and synthesis in stem cell-derived hepatocytes with a patient-specific mutation. Stem Cell Reports 16:309. https:\/\/doi.org\/10.1016\/j.stemcr.2020.12.008","journal-title":"Stem Cell Reports"},{"key":"4541_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/srep35434","volume":"6","author":"DFG Hendriks","year":"2016","unstructured":"Hendriks DFG, Fredriksson Puigvert L, Messner S, Mortiz W, Ingelman-Sundberg M (2016) Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability. Sci Rep 6:35434. https:\/\/doi.org\/10.1038\/srep35434","journal-title":"Sci Rep"},{"key":"4541_CR138","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/1087057108316702","volume":"13","author":"K Heredi-Szabo","year":"2008","unstructured":"Heredi-Szabo K, Kis E, Molnar E, Gyorfi A, Krajcsi P (2008) Characterization of 5(6)-carboxy-2,\u20327\u2032-dichlorofluorescein transport by MRP2 and utilization of this substrate as a fluorescent surrogate for LTC4. SLAS Discov 13:295\u2013301. https:\/\/doi.org\/10.1177\/1087057108316702","journal-title":"SLAS Discov"},{"key":"4541_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/srep06835","volume":"4","author":"KJ Herr","year":"2014","unstructured":"Herr KJ, Tsang YHN, Ong JWE, Li Q, Yap LL, Yu W, Yin H, Bogorad RL, Dahlman JE, Chan YG, Bay BH, Singaraja R, Anderson DG, Koteliansky V, Viasnoff V, Thiery JP (2014) Loss of \u03b1-catenin elicits a cholestatic response and impairs liver regeneration. Sci Rep 4:6835-. https:\/\/doi.org\/10.1038\/srep06835","journal-title":"Sci Rep"},{"key":"4541_CR140","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.clpt.2005.05.011","volume":"405","author":"RH Ho","year":"2010","unstructured":"Ho RH, Kim RB (2010) Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3. Anal Biochem 405:50\u201358. https:\/\/doi.org\/10.1016\/j.clpt.2005.05.011","journal-title":"Anal Biochem"},{"key":"4541_CR141","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0088011","volume":"9","author":"MO Hoeke","year":"2014","unstructured":"Hoeke MO, Heegsma J, Hoekstra M, Moshage H, Faber KN (2014) Human FXR regulates SHP expression through direct binding to an LRH-1 binding site, independent of an IR-1 and LRH-1. PLoS ONE 9:e88011. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0088011","journal-title":"PLoS ONE"},{"key":"4541_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19469-x","volume":"12","author":"S Horiuchi","year":"2022","unstructured":"Horiuchi S, Kuroda Y, Oyafuso R, Komizu Y, Takaki T, Maeda K, Ishida S (2022) Construction of a culture protocol for functional bile canaliculi formation to apply human iPS cell-derived hepatocytes for cholestasis evaluation. Sci Rep 12:15192. https:\/\/doi.org\/10.1038\/s41598-022-19469-x","journal-title":"Sci Rep"},{"key":"4541_CR143","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1007\/s00204-024-03757-8","volume":"98","author":"S Horiuchi","year":"2024","unstructured":"Horiuchi S, Kuroda Y, Oyafuso R, Komizu Y, Maeda K, Ishida S (2024) Formation of functional, extended bile canaliculi, and increased bile acid production in sandwich-cultured human cryopreserved hepatocytes using commercially available culture medium. Arch Toxicol 98:2605\u20132617. https:\/\/doi.org\/10.1007\/s00204-024-03757-8","journal-title":"Arch Toxicol"},{"key":"4541_CR144","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1517\/14740338.6.6.673","volume":"6","author":"SH Hussaini","year":"2007","unstructured":"Hussaini SH, Farrington EA (2007) Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf 6:673\u2013684. https:\/\/doi.org\/10.1517\/14740338.6.6.673","journal-title":"Expert Opin Drug Saf"},{"key":"4541_CR145","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0003-2697(89)90581-2","volume":"182","author":"PB Hylemon","year":"1989","unstructured":"Hylemon PB, Studer EJ, Pandak WM, Heuman DM, Vlahcevic ZR, Chiang JYL (1989) Simultaneous measurement of cholesterol 7\u03b1-hydroxylase activity by reverse-phase high-performance liquid chromatography using both endogenous and exogenous [4-14C]cholesterol as substrate. Anal Biochem 182:212\u2013216. https:\/\/doi.org\/10.1016\/0003-2697(89)90581-2","journal-title":"Anal Biochem"},{"key":"4541_CR146","doi-asserted-by":"publisher","unstructured":"OECD (Organisation for Economic Co-operation and Development), Guidance document for the use of adverse outcome pathways in developing integrated approaches to testing and assessment (IATA), (2017). https:\/\/doi.org\/10.1787\/44BB06C1-EN.","DOI":"10.1787\/44BB06C1-EN"},{"key":"4541_CR147","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1083\/JCB.138.1.181","volume":"138","author":"M Itoh","year":"1997","unstructured":"Itoh M, Nagafuchi A, Moroi S, Tsukita S (1997) Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to alpha catenin and actin filaments. J Cell Biol 138:181\u2013192. https:\/\/doi.org\/10.1083\/JCB.138.1.181","journal-title":"J Cell Biol"},{"key":"4541_CR148","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1021\/acs.molpharmaceut.5b00664","volume":"13","author":"S Izumi","year":"2016","unstructured":"Izumi S, Nozaki Y, Komori T, Takenaka O, Maeda K, Kusuhara H, Sugiyama Y (2016) Investigation of fluorescein derivatives as substrates of organic anion transporting polypeptide (OATP) 1B1 to develop sensitive fluorescence-based OATP1B1 inhibition assays. Mol Pharm 13:438\u2013448. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00664","journal-title":"Mol Pharm"},{"key":"4541_CR149","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1021\/acs.molpharmaceut.7b00366","volume":"14","author":"E J\u00e4rvinen","year":"2017","unstructured":"J\u00e4rvinen E, Troberg J, Kidron H, Finel M (2017) Selectivity in the efflux of glucuronides by human transporters: MRP4 is highly active toward 4-methylumbelliferone and 1-naphthol glucuronides, while MRP3 exhibits stereoselective propranolol glucuronide transport. Mol Pharm 14:3299\u20133311. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00366","journal-title":"Mol Pharm"},{"issue":"11","key":"4541_CR150","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/S00204-019-02585-5","volume":"93","author":"J Jiang","year":"2019","unstructured":"Jiang J, Pieterman CD, Ertaylan G, Peeters RLM, de Kok TMCM (2019) The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro. Arch Toxicol 93(11):3067\u20133098. https:\/\/doi.org\/10.1007\/S00204-019-02585-5","journal-title":"Arch Toxicol"},{"key":"4541_CR151","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.bbrc.2020.10.039","volume":"534","author":"L Jiang","year":"2021","unstructured":"Jiang L, Xiao D, Li Y, Dai S, Qu L, Chen X, Guo M, Wei H, Chen Y (2021) Structural basis of tropifexor as a potent and selective agonist of farnesoid X receptor. Biochem Biophys Res Commun 534:1047\u20131052. https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.039","journal-title":"Biochem Biophys Res Commun"},{"key":"4541_CR152","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1007\/s00204-023-03583-4","volume":"97","author":"J Jiang","year":"2023","unstructured":"Jiang J, van Ertvelde J, Ertaylan G, Peeters R, Jennen D, de Kok TM, Vinken M (2023) Unraveling the mechanisms underlying drug-induced cholestatic liver injury: identifying key genes using machine learning techniques on human in vitro data sets. Arch Toxicol 97:2969\u20132981. https:\/\/doi.org\/10.1007\/s00204-023-03583-4","journal-title":"Arch Toxicol"},{"key":"4541_CR153","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1124\/DMD.106.010033","volume":"34","author":"E Jigorel","year":"2006","unstructured":"Jigorel E, Le Vee M, Boursier-Neyret C, Parmentier Y, Fardel O (2006) Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos 34:1756\u20131763. https:\/\/doi.org\/10.1124\/DMD.106.010033","journal-title":"Drug Metab Dispos"},{"key":"4541_CR154","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0003-2697(89)90608-8","volume":"182","author":"MR Johnson","year":"1989","unstructured":"Johnson MR, Barnes S, Diasio RB (1989) Radioassay of bile acid coenzyme A:glycine\/taurine: N-acyltransferase using an n-butanol solvent extraction procedure. Anal Biochem 182:360\u2013365. https:\/\/doi.org\/10.1016\/0003-2697(89)90608-8","journal-title":"Anal Biochem"},{"key":"4541_CR155","doi-asserted-by":"publisher","first-page":"10227","DOI":"10.1016\/s0021-9258(18)99213-6","volume":"266","author":"MR Johnson","year":"1991","unstructured":"Johnson MR, Barnes S, Kwakye JB, Diasio RB (1991) Purification and characterization of bile acid-CoA:amino acid N-acyltransferase from human liver. J Biol Chem 266:10227\u201310233. https:\/\/doi.org\/10.1016\/s0021-9258(18)99213-6","journal-title":"J Biol Chem"},{"key":"4541_CR156","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/J.JSBMB.2011.06.012","volume":"130","author":"JW Jonker","year":"2011","unstructured":"Jonker JW, Liddle C, Downes M (2011) FXR and PXR: potential therapeutic targets in cholestasis. J Steroid Biochem Mol Biol 130:147. https:\/\/doi.org\/10.1016\/J.JSBMB.2011.06.012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4541_CR157","first-page":"1","volume":"1","author":"S Joseph","year":"2025","unstructured":"Joseph S, de Buyl S, Leclercq IA, Serafimov K, Feron O, Clerbaux LA (2025) Towards the clinical use of peripheral bile acids: Recommendations to limit their preanalytical and analytical sources of variability. Pract Lab Med 1:1","journal-title":"Pract Lab Med"},{"key":"4541_CR158","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1021\/jm300212s","volume":"55","author":"M Karlgren","year":"2012","unstructured":"Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P (2012) Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug\u2013drug interactions. J Med Chem 55:4740\u20134763. https:\/\/doi.org\/10.1021\/jm300212s","journal-title":"J Med Chem"},{"key":"4541_CR159","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1074\/jbc.M109326200","volume":"277","author":"HR Kast","year":"2002","unstructured":"Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer S, Willson TM, Edwards PA (2002) Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277:2908\u20132915. https:\/\/doi.org\/10.1074\/jbc.M109326200","journal-title":"J Biol Chem"},{"key":"4541_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/J.TIV.2022.105533","volume":"87","author":"V Kastrinou Lampou","year":"2023","unstructured":"Kastrinou Lampou V, Poller B, Huth F, Fischer A, Kullak-Ublick GA, Arand M, Schadt HS, Camenisch G (2023) Novel insights into bile acid detoxification via CYP, UGT and SULT enzymes. Toxicol in Vitro 87:105533. https:\/\/doi.org\/10.1016\/J.TIV.2022.105533","journal-title":"Toxicol in Vitro"},{"key":"4541_CR161","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/S00204-024-03895-Z\/FIGURES\/6","volume":"99","author":"V Kastrinou-Lampou","year":"2024","unstructured":"Kastrinou-Lampou V, Rodr\u00edguez-P\u00e9rez R, Poller B, Huth F, Schadt HS, Kullak-Ublick GA, Arand M, Camenisch G (2024a) Drug-induced cholestasis (DIC) predictions based on in vitro inhibition of major bile acid clearance mechanisms. Arch Toxicol 99:377\u2013391. https:\/\/doi.org\/10.1007\/S00204-024-03895-Z\/FIGURES\/6","journal-title":"Arch Toxicol"},{"issue":"10","key":"4541_CR162","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1007\/S00204-024-03794-3","volume":"98","author":"V Kastrinou-Lampou","year":"2024","unstructured":"Kastrinou-Lampou V, Rodr\u00edguez-P\u00e9rez R, Poller B, Huth F, G\u00e1borik Z, M\u00e1rtonn\u00e9-T\u00f3th B, Temesszentandr\u00e1si-Ambrus C, Schadt HS, Kullak-Ublick GA, Arand M, Camenisch G (2024b) Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC). Arch Toxicol 98(10):3409\u20133424. https:\/\/doi.org\/10.1007\/S00204-024-03794-3","journal-title":"Arch Toxicol"},{"key":"4541_CR163","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/J.JCMGH.2022.11.008","volume":"15","author":"S Kaur","year":"2023","unstructured":"Kaur S, Kidambi S, Ortega-Ribera M, Thuy LTT, Nieto N, Cogger VC, Xie WF, Tacke F, Gracia-Sancho J (2023) In vitro models for the study of liver biology and diseases: advances and limitations. Cell Mol Gastroenterol Hepatol 15:559\u2013571. https:\/\/doi.org\/10.1016\/J.JCMGH.2022.11.008","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4541_CR164","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/164_2019_231","volume":"256","author":"V Keitel","year":"2019","unstructured":"Keitel V, Dr\u00f6ge C, H\u00e4ussinger D (2019) Targeting FXR in cholestasis. Handb Exp Pharmacol 256:299\u2013324. https:\/\/doi.org\/10.1007\/164_2019_231","journal-title":"Handb Exp Pharmacol"},{"key":"4541_CR165","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/CPT.1222","volume":"104","author":"JG Kenna","year":"2018","unstructured":"Kenna JG, Taskar KS, Battista C, Bourdet DL, Brouwer KLR, Brouwer KR, Dai D, Funk C, Hafey MJ, Lai Y, Maher J, Pak YA, Pedersen JM, Polli JW, Rodrigues AD, Watkins PB, Yang K, Yucha RW (2018) Can bile salt export pump inhibition testing in drug discovery and development reduce liver injury risk? An international transporter consortium perspective. Clin Pharmacol Ther 104:916. https:\/\/doi.org\/10.1002\/CPT.1222","journal-title":"Clin Pharmacol Ther"},{"key":"4541_CR166","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/toxics12020126\/s1","volume":"12","author":"S Kim","year":"2024","unstructured":"Kim S, Kang K, Kim H, Seo M (2024a) In vitro toxicity screening of fifty complex mixtures in HepG2 cells. Toxics 12:126. https:\/\/doi.org\/10.3390\/toxics12020126\/s1","journal-title":"Toxics"},{"key":"4541_CR167","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.toxlet.2024.10.004","volume":"401","author":"C Kim","year":"2024","unstructured":"Kim C, Zhu Z, Barbazuk WB, Bacher RL, Vulpe CD (2024b) Time-course characterization of whole-transcriptome dynamics of HepG2\/C3A spheroids and its toxicological implications. Toxicol Lett 401:125\u2013138. https:\/\/doi.org\/10.1016\/j.toxlet.2024.10.004","journal-title":"Toxicol Lett"},{"key":"4541_CR168","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/ADDE86","author":"MK Kim","year":"2025","unstructured":"Kim MK, Paek K, Park K, Tak S, Na K, Choi JH, Woo SM, Kim HB, Yoon YM, Chung S, Kim JA (2025) A hepatic zonation chip with an oxygen concentration gradient embracing the spatial distribution of metabolic function. Biofabrication. https:\/\/doi.org\/10.1088\/1758-5090\/ADDE86","journal-title":"Biofabrication"},{"key":"4541_CR169","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1021\/mp300379q","volume":"9","author":"E Kimoto","year":"2012","unstructured":"Kimoto E, Yoshida K, Balogh LM, Bi YA, Maeda K, El-Kattan A, Sugiyama Y, Lai Y (2012) Characterization of organic anion transporting polypeptide (OATP) expression and its functional contribution to the uptake of substrates in human hepatocytes. Mol Pharm 9:3535\u20133542. https:\/\/doi.org\/10.1021\/mp300379q","journal-title":"Mol Pharm"},{"key":"4541_CR170","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.tiv.2011.11.002","volume":"26","author":"E Kis","year":"2012","unstructured":"Kis E, Ioja E, Rajnai Z, Jani M, M\u00e9hn D, Her\u00e9di-Szab\u00f3 K, Krajcsi P (2012) BSEP inhibition \u2013 in vitro screens to assess cholestatic potential of drugs. Toxicol in Vitro 26:1294\u20131299. https:\/\/doi.org\/10.1016\/j.tiv.2011.11.002","journal-title":"Toxicol in Vitro"},{"key":"4541_CR171","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2131\/jts.48.251","volume":"48","author":"T Kitaguchi","year":"2023","unstructured":"Kitaguchi T, Horiuchi S, Kuroda Y, Ohno K, Kobayashi K, Tanaka M, Ishida S (2023) Construction of extended and functional bile canaliculi using long-term sandwich-cultured cryopreserved human hepatocytes and the application of hepatocytes for predicting the biliary excretion of pharmaceutical and food-related compounds. J Toxicol Sci 48:251\u2013261. https:\/\/doi.org\/10.2131\/jts.48.251","journal-title":"J Toxicol Sci"},{"key":"4541_CR172","doi-asserted-by":"publisher","DOI":"10.1002\/AWS2.1243","volume":"3","author":"EJ Kleiner","year":"2021","unstructured":"Kleiner EJ, Sanan T, Smith SJ, Pressman JG, Abulikemu G, Crone BC, Wahman DG (2021) Practical implications of perfluoroalkyl substances adsorption on bottle materials: isotherms. AWWA Water Sci 3:e1243. https:\/\/doi.org\/10.1002\/AWS2.1243","journal-title":"AWWA Water Sci"},{"key":"4541_CR173","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/toxsci\/kfy026","volume":"163","author":"C Knebel","year":"2018","unstructured":"Knebel C, Neeb J, Zahn E, Schmidt F, Carazo A, Holas O, Pavek P, P\u00fcschel GP, Zanger UM, S\u00fcssmuth R, Lampen A, Marx-Stoelting P, Braeuning A (2018) Unexpected effects of propiconazole, tebuconazole, and their mixture on the receptors CAR and PXR in human liver cells. Toxicol Sci 163:170\u2013181. https:\/\/doi.org\/10.1093\/toxsci\/kfy026","journal-title":"Toxicol Sci"},{"key":"4541_CR174","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1124\/dmd.113.054304","volume":"42","author":"K K\u00f6ck","year":"2014","unstructured":"K\u00f6ck K, Ferslew BC, Netterberg I, Yang K, Urban TJ, Swaan PW, Stewart PW, Brouwer KLR (2014) Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4. Drug Metab Dispos 42:665\u2013674. https:\/\/doi.org\/10.1124\/dmd.113.054304","journal-title":"Drug Metab Dispos"},{"key":"4541_CR175","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1021\/mp300171p","volume":"9","author":"N Kotani","year":"2012","unstructured":"Kotani N, Maeda K, Debori Y, Camus S, Li R, Chesne C, Sugiyama Y (2012) Expression and transport function of drug uptake transporters in differentiated HepaRG cells. Mol Pharm 9:3434\u20133441. https:\/\/doi.org\/10.1021\/mp300171p","journal-title":"Mol Pharm"},{"key":"4541_CR176","doi-asserted-by":"publisher","first-page":"682","DOI":"10.14573\/altex.1909271","volume":"36","author":"A Krebs","year":"2019","unstructured":"Krebs A, Waldmann T, Wilks MF, van Vugt-Lussenburg BMA, van der Burg B, Terron A, Steger-Hartmann T, Ruegg J, Rovida C, Pedersen E, Pallocca G, Luijten M, Leite SB, Kustermann S, Kamp H, Hoeng J, Hewitt P, Herzler M, Hengstler JG, Heinonen T, Hartung T, Hardy B, Gantner F, Fritsche E, Fant K, Ezendam J, Exner T, Dunkern T, Dietrich DR, Coecke S, Busquet F, Braeuning A, Bondarenko O, Bennekou SH, Beilmann M, Leist M (2019) Template for the description of cell-based toxicological test methods to allow evaluation and regulatory use of the data. Altex 36:682\u2013699. https:\/\/doi.org\/10.14573\/altex.1909271","journal-title":"Altex"},{"key":"4541_CR177","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091912","volume":"18","author":"AP Kudin","year":"2017","unstructured":"Kudin AP, Mawasi H, Eisenkraft A, Elger CE, Bialer M, Kunz WS (2017) Mitochondrial liver toxicity of valproic acid and its acid derivatives is related to inhibition of \u03b1-lipoamide dehydrogenase. Int J Mol Sci 18:1912. https:\/\/doi.org\/10.3390\/ijms18091912","journal-title":"Int J Mol Sci"},{"key":"4541_CR178","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jhep.2025.05.032","volume":"83","author":"R Kudira","year":"2025","unstructured":"Kudira R, Yang ZF, Osuji I, Damen MSMA, Yang vom Hofe A, Singh M, Karns R, Bariya P, Pfuhler L, Mullen M, Taylor A, Ji H, Lages CS, Shi T, Pasula S, Wayman JA, Bernieh A, Zhang W, Chougnet CA, Hildeman DA, Tiao GM, Huppert SS, Subramanian S, Salomonis N, Miraldi ER, Miethke AG (2025) Bile acids engage the SIPR-STAT3 signaling axis to modulate regulatory T cell responses in fibrosing cholangiopathies. J Hepatol 83:1128\u20131141. https:\/\/doi.org\/10.1016\/j.jhep.2025.05.032","journal-title":"J Hepatol"},{"key":"4541_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/J.TOX.2025.154378","volume":"521","author":"G Kulkarni","year":"2026","unstructured":"Kulkarni G, Chen L, Sang J, Seo JH, Grall R, Wang Y, Gilbride P, Yuan YC, Albaum-Getzen M, McCormack J, Ma J, Fanelli A, Meng L, Xu B, Huang XH, Marshall T, Singh H, Qian X, Xie Z, Bai H, Si L, Ding C, Ouedraogo G, Kuang R, Xie X, Bai H (2026) A scalable human liver-on-a-chip platform for predictive safety assessment. Toxicology 521:154378. https:\/\/doi.org\/10.1016\/J.TOX.2025.154378","journal-title":"Toxicology"},{"key":"4541_CR180","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/s0168-8278(00)80411-0","volume":"123","author":"GA Kullak-Ublick","year":"2002","unstructured":"Kullak-Ublick GA, Beuers U, Paumgartner G (2002) The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastroenterology 123:1649\u20131658. https:\/\/doi.org\/10.1016\/s0168-8278(00)80411-0","journal-title":"Gastroenterology"},{"key":"4541_CR181","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.tiv.2018.01.023","volume":"48","author":"JA Kyffin","year":"2018","unstructured":"Kyffin JA, Sharma P, Leedale J, Colley HE, Murdoch C, Mistry P, Webb SD (2018) Impact of cell types and culture methods on the functionality of in vitro liver systems \u2013 a review of cell systems for hepatotoxicity assessment. Toxicol in Vitro 48:262\u2013275. https:\/\/doi.org\/10.1016\/j.tiv.2018.01.023","journal-title":"Toxicol in Vitro"},{"key":"4541_CR182","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/j.tiv.2013.07.003","volume":"27","author":"M Le Vee","year":"2013","unstructured":"Le Vee M, Noel G, Jouan E, Stieger B, Fardel O (2013) Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells. Toxicol in Vitro 27:1979\u20131986. https:\/\/doi.org\/10.1016\/j.tiv.2013.07.003","journal-title":"Toxicol in Vitro"},{"key":"4541_CR183","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/bdd.2333","volume":"43","author":"M Le V\u00e9e","year":"2022","unstructured":"Le V\u00e9e M, Moreau A, Jouan E, Denizot C, Parmentier Y, Fardel O (2022) Inhibition of canalicular and sinusoidal taurocholate efflux by cholestatic drugs in human hepatoma HepaRG cells. Biopharm Drug Dispos 43:265\u2013271. https:\/\/doi.org\/10.1002\/bdd.2333","journal-title":"Biopharm Drug Dispos"},{"key":"4541_CR184","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1007\/S00204-017-2045-3","volume":"91","author":"M Leist","year":"2017","unstructured":"Leist M, Ghallab A, Graepel R, Marchan R, Hassan R, Bennekou SH, Limonciel A, Vinken M, Schildknecht S, Waldmann T, Danen E, van Ravenzwaay B, Kamp H, Gardner I, Godoy P, Bois FY, Braeuning A, Reif R, Oesch F, Drasdo D, H\u00f6hme S, Schwarz M, Hartung T, Braunbeck T, Beltman J, Vrieling H, Sanz F, Forsby A, Gadaleta D, Fisher C, Kelm J, Fluri D, Ecker G, Zdrazil B, Terron A, Jennings P, van der Burg B, Dooley S, Meijer AH, Willighagen E, Martens M, Evelo C, Mombelli E, Taboureau O, Mantovani A, Hardy B, Koch B, Escher S, van Thriel C, Cadenas C, Kroese D, van de Water B, Hengstler JG (2017) Adverse outcome pathways: opportunities, limitations and open questions. Arch Toxicol 91:3477\u20133505. https:\/\/doi.org\/10.1007\/S00204-017-2045-3","journal-title":"Arch Toxicol"},{"key":"4541_CR185","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087548","volume":"9","author":"EI Lepist","year":"2014","unstructured":"Lepist EI, Gillies H, Smith W, Hao J, Hubert C, St Claire RL, Brouwer KR, Ray AS (2014) Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes. PLoS ONE 9:e87548. https:\/\/doi.org\/10.1371\/journal.pone.0087548","journal-title":"PLoS ONE"},{"key":"4541_CR186","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1124\/jpet.106.119073","volume":"321","author":"EM Leslie","year":"2007","unstructured":"Leslie EM, Watkins PB, Kim RB, Brouwer KLR (2007) Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP\/SLC10A1) by bosentan: a mechanism for species differences in hepatotoxicity. J Pharmacol Exp Ther 321:1170\u20131178. https:\/\/doi.org\/10.1124\/jpet.106.119073","journal-title":"J Pharmacol Exp Ther"},{"key":"4541_CR187","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1124\/jpet.120.000449","volume":"377","author":"M Leuenberger","year":"2021","unstructured":"Leuenberger M, H\u00e4usler S, H\u00f6hn V, Euler A, Stieger B, Lochner M (2021) Characterization of novel fluorescent bile salt derivatives for studying human bile salt and organic anion transporters. J Pharmacol Exp Ther 377:346\u2013357. https:\/\/doi.org\/10.1124\/jpet.120.000449","journal-title":"J Pharmacol Exp Ther"},{"key":"4541_CR188","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1124\/dmd.105.007575","volume":"34","author":"T Li","year":"2006","unstructured":"Li T, Chiang JYL (2006) Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4\u03b1 and coactivators, and suppression of small heterodimer partner gene expression. Drug Metab Dispos 34:756\u2013764. https:\/\/doi.org\/10.1124\/dmd.105.007575","journal-title":"Drug Metab Dispos"},{"key":"4541_CR189","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/hep.21183","volume":"43","author":"T Li","year":"2006","unstructured":"Li T, Jahan A, Chiang JYL (2006) Bile acids and cytokines inhibit the human cholesterol 7\u03b1-hydroxylase gene via the JNK\/c-Jun pathway. Hepatology 43:1202. https:\/\/doi.org\/10.1002\/hep.21183","journal-title":"Hepatology"},{"key":"4541_CR190","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3349\/YMJ.2019.60.11.1045","volume":"60","author":"W Lian","year":"2019","unstructured":"Lian W, Liu X, Chen W (2019) TNF\u03b1 induces multidrug resistance-associated protein 4 expression through p38-E2F1-Nrf2 signaling in obstructive cholestasis. Yonsei Med J 60:1045\u20131053. https:\/\/doi.org\/10.3349\/YMJ.2019.60.11.1045","journal-title":"Yonsei Med J"},{"key":"4541_CR191","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41401-024-01357-x","volume":"46","author":"HF Liang","year":"2025","unstructured":"Liang HF, Yang X, Li HL, Li X, Tian JN, Su HG, Huang M, Fang JH, Bi HC (2025) Activation of pregnane X receptor protects against cholestatic liver injury by inhibiting hepatocyte pyroptosis. Acta Pharmacol Sin 46:147\u2013158","journal-title":"Acta Pharmacol Sin"},{"key":"4541_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111283","volume":"139","author":"D Lichtenstein","year":"2020","unstructured":"Lichtenstein D, Luckert C, Alarcan J, de Sousa G, Gioutlakis M, Katsanou ES, Konstantinidou P, Machera K, Milani ES, Peijnenburg A, Rahmani R, Rijkers D, Spyropoulou A, Stamou M, Stoopen G, Sturla SJ, Wollscheid B, Zucchini-Pascal N, Braeuning A, Lampen A (2020) An adverse outcome pathway-based approach to assess steatotic mixture effects of hepatotoxic pesticides in vitro. Food Chem Toxicol 139:111283. https:\/\/doi.org\/10.1016\/j.fct.2020.111283","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"4541_CR193","doi-asserted-by":"publisher","DOI":"10.1186\/S40348-025-00211-2","volume":"12","author":"K Linz","year":"2025","unstructured":"Linz K, Wachter F, Cla\u00dfen M, Zierk J, Voggenreiter T, Schnell A, Grieshaber Bouyer Mandelbaum H, Woelfle J, Knieling F, Hoerning A, Rauh M, Regensburger AP (2025) Serum bile acid profiles in pediatric gastrointestinal, hepatic and biliary diseases. Mol Cell Pediatr 12(1):23. https:\/\/doi.org\/10.1186\/S40348-025-00211-2","journal-title":"Mol Cell Pediatr"},{"key":"4541_CR194","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/J.BBRC.2011.03.066","volume":"407","author":"YH Liu","year":"2011","unstructured":"Liu YH, Ho CC, Cheng CC, Chao WT, Pei RJ, Hsu YH, Lai YS (2011) Cytokeratin 18-mediated disorganization of intermediate filaments is induced by degradation of plectin in human liver cells. Biochem Biophys Res Commun 407:575\u2013580. https:\/\/doi.org\/10.1016\/J.BBRC.2011.03.066","journal-title":"Biochem Biophys Res Commun"},{"key":"4541_CR195","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/toxsci\/kfu151","volume":"141","author":"J Liu","year":"2014","unstructured":"Liu J, Lu H, Lu YF, Lei X, Cui JY, Ellis E, Strom SC, Klaassen CD (2014) Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures. Toxicol Sci 141:538\u2013546. https:\/\/doi.org\/10.1093\/toxsci\/kfu151","journal-title":"Toxicol Sci"},{"key":"4541_CR196","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.3892\/mmr.2018.8779","volume":"17","author":"YT Liu","year":"2018","unstructured":"Liu YT, Liu W, Zhu GY, Wang FL, Chen Q (2018) Involvement of multidrug resistance protein 4 in the hepatocyte efflux of lamivudine and entecavir. Mol Med Rep 17:7113. https:\/\/doi.org\/10.3892\/mmr.2018.8779","journal-title":"Mol Med Rep"},{"key":"4541_CR197","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1021\/acs.jmedchem.0c01484","volume":"64","author":"Y Liu","year":"2020","unstructured":"Liu Y, Ruan H, Li Y, Sun G, Liu X, He W, Mao F, He M, Yan L, Zhong G, Yan H, Li W, Zhang Z (2020) Potent and specific inhibition of NTCP-mediated HBV\/HDV infection and substrate transporting by a novel, oral-available cyclosporine A analogue. J Med Chem 64:543\u2013565. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01484","journal-title":"J Med Chem"},{"key":"4541_CR198","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43109-1","volume":"14","author":"H Liu","year":"2023","unstructured":"Liu H, Irobalieva RN, Kowal J, Ni D, Nosol K, Bang-S\u00f8rensen R, Lancien L, Stahlberg H, Stieger B, Locher KP (2023) Structural basis of bile salt extrusion and small-molecule inhibition in human BSEP. Nat Commun 14:7296-. https:\/\/doi.org\/10.1038\/s41467-023-43109-1","journal-title":"Nat Commun"},{"key":"4541_CR199","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/jcb.1982.240200409","volume":"20","author":"RB Low","year":"1982","unstructured":"Low RB, Low ES, Chaponnier C, Mitchell JW, Gabbiani G (1982) Effect of phalloidin on liver actin distribution, content, and turnover. J Cell Biochem 20:393\u2013407. https:\/\/doi.org\/10.1002\/jcb.1982.240200409","journal-title":"J Cell Biochem"},{"key":"4541_CR200","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.toxlet.2013.06.243","volume":"222","author":"C Luckert","year":"2013","unstructured":"Luckert C, Ehlers A, Buhrke T, Seidel A, Lampen A, Hessel S (2013) Polycyclic aromatic hydrocarbons stimulate human CYP3A4 promoter activity via PXR. Toxicol Lett 222:180\u2013188. https:\/\/doi.org\/10.1016\/j.toxlet.2013.06.243","journal-title":"Toxicol Lett"},{"key":"4541_CR201","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1021\/acs.chemrestox.8b00112","volume":"31","author":"C Luckert","year":"2018","unstructured":"Luckert C, Braeuning A, De Sousa G, Durinck S, Katsanou ES, Konstantinidou P, Machera K, Milani ES, Peijnenburg AACM, Rahmani R, Rajkovic A, Rijkers D, Spyropoulou A, Stamou M, Stoopen G, Sturla S, Wollscheid B, Zucchini-Pascal N, Lampen A (2018) Adverse outcome pathway-driven analysis of liver steatosis in vitro: a case study with cyproconazole. Chem Res Toxicol 31:784\u2013798. https:\/\/doi.org\/10.1021\/acs.chemrestox.8b00112","journal-title":"Chem Res Toxicol"},{"key":"4541_CR202","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/S11095-013-0986-7","volume":"30","author":"Y Ma","year":"2013","unstructured":"Ma Y, Huang Y, Yan L, Gao M, Liu D (2013) Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance. Pharm Res 30:1447. https:\/\/doi.org\/10.1007\/S11095-013-0986-7","journal-title":"Pharm Res"},{"key":"4541_CR203","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0092-8674(80)90619-4","volume":"20","author":"S MacLean-Fletcher","year":"1980","unstructured":"MacLean-Fletcher S, Pollard TD (1980) Mechanism of action of cytochalasin B on actin. Cell 20:329\u2013341. https:\/\/doi.org\/10.1016\/0092-8674(80)90619-4","journal-title":"Cell"},{"key":"4541_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2025.154210","volume":"517","author":"A Maerten","year":"2025","unstructured":"Maerten A, Drees A, Jiang J, Sanz-Serrano J, Devisscher L, Vinken M (2025a) In vitro test battery for testing molecular initiating events in chemical-induced cholestasis. Toxicology 517:154210. https:\/\/doi.org\/10.1016\/j.tox.2025.154210","journal-title":"Toxicology"},{"key":"4541_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2025.180975","volume":"1008","author":"A Maerten","year":"2025","unstructured":"Maerten A, Callewaert E, Sanz-Serrano J, Devisscher L, Vinken M (2025b) Effects of per- and polyfluoroalkyl substances on molecular initiating events of cholestatic liver injury. Sci Total Environ 1008:180975. https:\/\/doi.org\/10.1016\/j.scitotenv.2025.180975","journal-title":"Sci Total Environ"},{"key":"4541_CR206","doi-asserted-by":"publisher","DOI":"10.1021\/acs.est.6c04152","author":"A Maerten","year":"2026","unstructured":"Maerten A, Ritz J, Devisscher L, Vinken M (2026) Ultrashort-chain per- and polyfluoroalkyl substances and cholestasis: in vitro evidence of liver dysfunction from emerging environmental contaminants. Environ Sci Technol. https:\/\/doi.org\/10.1021\/acs.est.6c04152","journal-title":"Environ Sci Technol"},{"key":"4541_CR207","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/bdd.527","volume":"28","author":"Y Mano","year":"2007","unstructured":"Mano Y, Usui T, Kamimura H (2007) Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance\u2013associated protein 2. Biopharm Drug Dispos 28:13\u201318. https:\/\/doi.org\/10.1002\/bdd.527","journal-title":"Biopharm Drug Dispos"},{"key":"4541_CR208","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1021\/mp0700357","volume":"4","author":"TL Marion","year":"2007","unstructured":"Marion TL, Leslie EM, Brouwer KLR (2007) Use of sandwich-cultured hepatocytes to evaluate impaired bile acid transport as a mechanism of drug-induced hepatotoxicity. Mol Pharm 4:911\u2013918. https:\/\/doi.org\/10.1021\/mp0700357","journal-title":"Mol Pharm"},{"key":"4541_CR209","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2012.02.002","volume":"261","author":"TL Marion","year":"2012","unstructured":"Marion TL, Perry CH, St. Claire RL, Brouwer KLR (2012) Endogenous bile acid disposition in rat and human sandwich-cultured hepatocytes. Toxicol Appl Pharmacol 261:1\u20139. https:\/\/doi.org\/10.1016\/j.taap.2012.02.002","journal-title":"Toxicol Appl Pharmacol"},{"key":"4541_CR210","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1053\/j.gastro.2005.05.009","volume":"129","author":"HU Marschall","year":"2005","unstructured":"Marschall HU, Wagner M, Zollner G, Fickert P, Diczfalusy U, Gumhold J, Silbert D, Fuchsbichler A, Benthin L, Grundstr\u00f6m R, Gustafsson U, Sahlin S, Einarsson C, Trauner M (2005) Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 129:476\u2013485. https:\/\/doi.org\/10.1053\/j.gastro.2005.05.009","journal-title":"Gastroenterology"},{"key":"4541_CR211","doi-asserted-by":"publisher","DOI":"10.1007\/S00204-026-04383-2","author":"J Matyjasiak","year":"2026","unstructured":"Matyjasiak J, Av\u00eervarei AC, Corradi M, Maerten A, Desaintes C, Sanz-Serrano J, Vinken M (2026) Mapping 3Rs and NAM research and innovation projects funded through European framework programmes since 2007. Arch Toxicol. https:\/\/doi.org\/10.1007\/S00204-026-04383-2","journal-title":"Arch Toxicol"},{"key":"4541_CR212","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2174\/138620710790596736","volume":"13","author":"J McKim","year":"2010","unstructured":"McKim J, James M (2010) 2010 Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance. Comb Chem High Throughput Screen 13:188. https:\/\/doi.org\/10.2174\/138620710790596736","journal-title":"Comb Chem High Throughput Screen"},{"key":"4541_CR213","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1124\/dmd.122.000859","volume":"51","author":"S Men","year":"2023","unstructured":"Men S, Wang H (2023) Phenobarbital in nuclear receptor activation: an update. Drug Metab Dispos 51:210\u2013218. https:\/\/doi.org\/10.1124\/dmd.122.000859","journal-title":"Drug Metab Dispos"},{"key":"4541_CR214","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jbiosc.2023.10.006","volume":"137","author":"T Messelmani","year":"2024","unstructured":"Messelmani T, Le Goff A, Soncin F, Souguir Z, Merlier F, Maubon N, Legallais C, Leclerc E, Jellali R (2024) Coculture model of a liver sinusoidal endothelial cell barrier and HepG2\/C3a spheroids-on-chip in an advanced fluidic platform. J Biosci Bioeng 137:64\u201375. https:\/\/doi.org\/10.1016\/j.jbiosc.2023.10.006","journal-title":"J Biosci Bioeng"},{"key":"4541_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2026.104242","volume":"115","author":"L Mettler","year":"2026","unstructured":"Mettler L, Riede J, Huth F, Lohasz C, Loskill P, Poller B (2026) Navigating ADME profiling challenges in microphysiological systems: evaluation of a liver-chip model for clearance prediction. J Pharm Sci 115:104242. https:\/\/doi.org\/10.1016\/j.xphs.2026.104242","journal-title":"J Pharm Sci"},{"key":"4541_CR216","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/GUT.52.2.300","volume":"52","author":"P Milkiewicz","year":"2003","unstructured":"Milkiewicz P, Chilton AP, Hubscher SG, Elias E (2003) Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2). Gut 52:300\u2013303. https:\/\/doi.org\/10.1136\/GUT.52.2.300","journal-title":"Gut"},{"key":"4541_CR217","doi-asserted-by":"publisher","DOI":"10.1038\/srep39573","volume":"6","author":"M Milkiewicz","year":"2016","unstructured":"Milkiewicz M, Klak M, Kempinska-Podhorodecka A, Wiechowska-Kozlowska A, Urasinska E, Blatkiewicz M, Wunsch E, Elias E, Milkiewicz P (2016) Impaired hepatic adaptation to chronic cholestasis induced by primary sclerosing cholangitis. Sci Rep 6:39573-. https:\/\/doi.org\/10.1038\/srep39573","journal-title":"Sci Rep"},{"key":"4541_CR218","doi-asserted-by":"publisher","DOI":"10.1002\/PRP2.1197;PAGE:STRING:ARTICLE\/CHAPTER","volume":"12","author":"G Minegishi","year":"2024","unstructured":"Minegishi G, Kobayashi Y, Fujikura M, Sano A, Kazuki Y, Kobayashi K (2024) Induction of hepatic CYP3A4 expression by cholesterol and cholic acid: alterations of gene expression, microsomal activity, and pharmacokinetics. Pharmacol Res Perspect 12:e1197. https:\/\/doi.org\/10.1002\/PRP2.1197;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"Pharmacol Res Perspect"},{"key":"4541_CR219","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/S00204-014-1283-X","volume":"89","author":"GS Miszczuk","year":"2015","unstructured":"Miszczuk GS, Barosso IR, Zucchetti AE, Boaglio AC, Pellegrino JM, S\u00e1nchez Pozzi EJ, Roma MG, Crocenzi FA (2015) Sandwich-cultured rat hepatocytes as an in vitro model to study canalicular transport alterations in cholestasis. Arch Toxicol 89:979\u2013990. https:\/\/doi.org\/10.1007\/S00204-014-1283-X","journal-title":"Arch Toxicol"},{"key":"4541_CR220","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/J.BBADIS.2018.01.015","volume":"1864","author":"GS Miszczuk","year":"2018","unstructured":"Miszczuk GS, Barosso IR, Larocca MC, Marrone J, Marinelli RA, Boaglio AC, S\u00e1nchez Pozzi EJ, Roma MG, Crocenzi FA (2018) Mechanisms of canalicular transporter endocytosis in the cholestatic rat liver. Biochimica Et Biophysica Acta (BBA) - Mol Basis Dis 1864:1072\u20131085. https:\/\/doi.org\/10.1016\/J.BBADIS.2018.01.015","journal-title":"Biochimica Et Biophysica Acta (BBA) - Mol Basis Dis"},{"key":"4541_CR221","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1124\/dmd.105.008748","volume":"34","author":"S Mita","year":"2006","unstructured":"Mita S, Suzuki H, Akita H, Hayashi H, Onuki R, Hofmann AF, Sugiyama Y (2006) Inhibition of bile acid transport across Na+\/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs. Drug Metab Dispos 34:1575\u20131581. https:\/\/doi.org\/10.1124\/dmd.105.008748","journal-title":"Drug Metab Dispos"},{"key":"4541_CR222","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0317568","volume":"20","author":"A Miyagawa-Hayashino","year":"2025","unstructured":"Miyagawa-Hayashino A, Imura T, Takezawa T, Hirai M, Shibata S, Ogi H, Tsujikawa T, Konishi E (2025) Activation of S1PR2 on macrophages and the hepatocyte S1PR2\/RhoA\/ROCK1\/MLC2 pathway in vanishing bile duct syndrome. PLoS ONE 20:e0317568. https:\/\/doi.org\/10.1371\/journal.pone.0317568","journal-title":"PLoS ONE"},{"key":"4541_CR223","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.1073\/pnas.130155097","volume":"97","author":"LB Moore","year":"2000","unstructured":"Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer SA (2000) St. John\u2019s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A 97:7500\u20137502. https:\/\/doi.org\/10.1073\/pnas.130155097","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4541_CR224","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","volume":"118","author":"RE Morgan","year":"2010","unstructured":"Morgan RE, Trauner M, van Staden CJ, Lee PH, Ramachandran B, Eschenberg M, Afshari CA, Qualls CW, Lightfoot-Dunn R, Hamadeh HK (2010) Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci 118:485\u2013500. https:\/\/doi.org\/10.1093\/toxsci\/kfq269","journal-title":"Toxicol Sci"},{"key":"4541_CR225","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/toxsci\/kft176","volume":"136","author":"RE Morgan","year":"2013","unstructured":"Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK (2013) A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicol Sci 136:216\u2013241. https:\/\/doi.org\/10.1093\/toxsci\/kft176","journal-title":"Toxicol Sci"},{"key":"4541_CR226","doi-asserted-by":"publisher","unstructured":"A.D. Mottino, T. Hoffman, F.A. Crocenzi, E.J. S\u00e1nchez Pozzi, M.G. Roma, M. Vore, Disruption of function and localization of tight junctional structures and Mrp2 in sustained estradiol-17beta-D-glucuronide-induced cholestasis, Am. J. Physiol. Gastrointest. Liver Physiol. 293 (2007) 391\u2013402. https:\/\/doi.org\/10.1152\/AJPGI.00496.2006.","DOI":"10.1152\/AJPGI.00496.2006"},{"key":"4541_CR227","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.tiv.2015.04.014","volume":"30","author":"SO Mueller","year":"2015","unstructured":"Mueller SO, Guillouzo A, Hewitt PG, Richert L (2015) Drug biokinetic and toxicity assessments in rat and human primary hepatocytes and HepaRG cells within the EU-funded Predict-IV project. Toxicol in Vitro 30:19\u201326. https:\/\/doi.org\/10.1016\/j.tiv.2015.04.014","journal-title":"Toxicol in Vitro"},{"key":"4541_CR228","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/J.JCMGH.2022.07.009","volume":"14","author":"A Mu\u00f1oz","year":"2022","unstructured":"Mu\u00f1oz A, Theusch E, Kuang YL, Nalula G, Peaslee C, Dorlhiac G, Landry MP, Streets A, Krauss RM, Iribarren C, Mattis AN, Medina MW (2022) Undifferentiated induced pluripotent stem cells as a genetic model for nonalcoholic fatty liver disease. Cell Mol Gastroenterol Hepatol 14:1174-1176.e6. https:\/\/doi.org\/10.1016\/J.JCMGH.2022.07.009","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4541_CR229","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2003705","volume":"6","author":"S Mutoh","year":"2013","unstructured":"Mutoh S, Sobhany M, Moore R, Perera L, Pedersen L, Sueyoshi T, Negishi M (2013) Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci Signal 6:ra31. https:\/\/doi.org\/10.1126\/scisignal.2003705","journal-title":"Sci Signal"},{"key":"4541_CR230","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1042\/BJ2880613","volume":"288","author":"T Nakai","year":"1992","unstructured":"Nakai T, Katagiri K, Hoshino M, Hayakawa T, Ohiwa T (1992) Microtubule-independent choleresis and anti-cholestatic action of tauroursodeoxycholate in colchicine-treated rat liver. Biochem J 288:613. https:\/\/doi.org\/10.1042\/BJ2880613","journal-title":"Biochem J"},{"issue":"1","key":"4541_CR231","doi-asserted-by":"publisher","DOI":"10.1038\/srep38694","volume":"6","author":"X Ni","year":"2016","unstructured":"Ni X, Gao Y, Wu Z, Ma L, Chen C, Wang L, Lin Y, Hui L, Pan G (2016) Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: a novel in vitro cholestatic model. Sci Rep 6(1):38694. https:\/\/doi.org\/10.1038\/srep38694","journal-title":"Sci Rep"},{"key":"4541_CR232","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1152\/ajpgi.1999.276.5.g1153","volume":"18","author":"K Niinuma","year":"2003","unstructured":"Niinuma K, Kato Y, Suzuki H, Tyson CA, Weizer V, Dabbs JE, Froehlich R, Green CE, Sugiyama Y (2003) Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans. Drug Metab Pharm 18:16\u201322. https:\/\/doi.org\/10.1152\/ajpgi.1999.276.5.g1153","journal-title":"Drug Metab Pharm"},{"key":"4541_CR233","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3177\/JNSV.66.370","volume":"66","author":"S Nishida","year":"2020","unstructured":"Nishida S, Ishizawa M, Kato S, Makishima M (2020) Vitamin D receptor deletion changes bile acid composition in mice orally administered chenodeoxycholic acid. J Nutr Sci Vitaminol 66:370\u2013374. https:\/\/doi.org\/10.3177\/JNSV.66.370","journal-title":"J Nutr Sci Vitaminol"},{"key":"4541_CR234","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00204-025-04263-1","volume":"100","author":"KS Nitsche","year":"2025","unstructured":"Nitsche KS, Sakolish C, Carmichael PL, Hewitt P, Bajaj P, Ferguson SS, Lloyd SM, Wilson SS, Bouwmeester H, Rusyn I (2025) Exploring the potential of liver microphysiological systems of varied configurations to model cholestatic chemical effects. Arch Toxicol 100:1033\u20131047. https:\/\/doi.org\/10.1007\/s00204-025-04263-1","journal-title":"Arch Toxicol"},{"key":"4541_CR235","doi-asserted-by":"publisher","DOI":"10.1016\/J.TOX.2025.154364","volume":"520","author":"KS Nitsche","year":"2026","unstructured":"Nitsche KS, Carmichael PL, Bakker W, Bouwmeester H, M\u00fcller I (2026) Characterising a HepaRG liver microphysiological system for individual bile acid secretion and chemical induced disruptions. Toxicology 520:154364. https:\/\/doi.org\/10.1016\/J.TOX.2025.154364","journal-title":"Toxicology"},{"key":"4541_CR236","doi-asserted-by":"publisher","unstructured":"OECD (Organisation for Economic Co-operation and Development), Users\u2019 handbook supplement to the guidance document for developing and assessing adverse outcome pathways, 2018. https:\/\/doi.org\/10.1787\/5jlv1m9d1g32-en.","DOI":"10.1787\/5jlv1m9d1g32-en"},{"key":"4541_CR237","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/cld.894","volume":"15","author":"FQ Onofrio","year":"2020","unstructured":"Onofrio FQ, Hirschfield GM (2020) The pathophysiology of cholestasis and its relevance to clinical practice. Clin Liver Dis (Hoboken) 15:110\u2013114. https:\/\/doi.org\/10.1002\/cld.894","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"4541_CR238","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/J.TIV.2016.03.008","volume":"34","author":"M Oorts","year":"2016","unstructured":"Oorts M, Baze A, Bachellier P, Heyd B, Zacharias T, Annaert P, Richert L (2016) Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes. Toxicol in Vitro 34:179\u2013186. https:\/\/doi.org\/10.1016\/J.TIV.2016.03.008","journal-title":"Toxicol in Vitro"},{"key":"4541_CR239","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1124\/jpet.121.000695","volume":"379","author":"M Oorts","year":"2021","unstructured":"Oorts M, van Brantegem P, Deferm N, Chatterjee S, Dreesen E, Cooreman A, Vinken M, Richert L, Annaert P (2021) Bosentan alters endo- and exogenous bile salt disposition in sandwich-cultured human hepatocytes. J Pharmacol Exp Ther 379:20\u201332. https:\/\/doi.org\/10.1124\/jpet.121.000695","journal-title":"J Pharmacol Exp Ther"},{"key":"4541_CR240","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/toxsci\/47.2.203","volume":"47","author":"DJ Orsler","year":"1999","unstructured":"Orsler DJ, Ahmed-Choudhury J, Chipman JK, Hammond T, Coleman R (1999) ANIT-induced disruption of biliary function in rat hepatocyte couplets. Toxicol Sci 47:203\u2013210. https:\/\/doi.org\/10.1093\/toxsci\/47.2.203","journal-title":"Toxicol Sci"},{"key":"4541_CR241","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/hep.24229","volume":"53","author":"MS Padda","year":"2011","unstructured":"Padda MS, Sanchez M, Akhtar AJ, Boyer JL (2011) Drug induced cholestasis. Hepatology 53:1377. https:\/\/doi.org\/10.1002\/hep.24229","journal-title":"Hepatology"},{"key":"4541_CR242","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/1875397301004010043","volume":"4","author":"A Paguio","year":"2010","unstructured":"Paguio A, Stecha P, Wood KV, Fan F (2010) Improved dual-luciferase reporter assays for nuclear receptors. Curr Chem Genomics 4:43. https:\/\/doi.org\/10.2174\/1875397301004010043","journal-title":"Curr Chem Genomics"},{"key":"4541_CR243","doi-asserted-by":"publisher","first-page":"34783","DOI":"10.1039\/C8RA06311G","volume":"8","author":"X Pang","year":"2018","unstructured":"Pang X, Zhang B, Mu G, Xia J, Xiang Q, Zhao X, Liu A, Du G, Cui Y (2018) Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approaches. RSC Adv 8:34783. https:\/\/doi.org\/10.1039\/C8RA06311G","journal-title":"RSC Adv"},{"key":"4541_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/J.MCE.2022.111678","volume":"552","author":"K Panzitt","year":"2022","unstructured":"Panzitt K, Zollner G, Marschall HU, Wagner M (2022) Recent advances on FXR-targeting therapeutics. Mol Cell Endocrinol 552:111678. https:\/\/doi.org\/10.1016\/J.MCE.2022.111678","journal-title":"Mol Cell Endocrinol"},{"key":"4541_CR245","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1007\/s00204-017-1930-0","volume":"91","author":"C Parmentier","year":"2017","unstructured":"Parmentier C, Couttet P, Wolf A, Zaccharias T, Heyd B, Bachellier P, Uteng M, Richert L (2017) Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes. Arch Toxicol 91:2879\u20132893. https:\/\/doi.org\/10.1007\/s00204-017-1930-0","journal-title":"Arch Toxicol"},{"key":"4541_CR246","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.toxlet.2018.06.1069","volume":"295","author":"C Parmentier","year":"2018","unstructured":"Parmentier C, Hendriks DFG, Heyd B, Bachellier P, Ingelman-Sundberg M, Richert L (2018) Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent. Toxicol Lett 295:187\u2013194. https:\/\/doi.org\/10.1016\/j.toxlet.2018.06.1069","journal-title":"Toxicol Lett"},{"key":"4541_CR247","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.bcp.2015.09.015","volume":"98","author":"I Patik","year":"2015","unstructured":"Patik I, Kovacsics D, N\u00e9met O, Gera M, V\u00e1rady G, Stieger B, Hagenbuch B, Szak\u00e1cs G, \u00d6zvegy-Laczka C (2015) Functional expression of the 11 human organic anion transporting polypeptides in insect cells reveals that sodium fluorescein is a general OATP substrate. Biochem Pharmacol 98:649\u2013658. https:\/\/doi.org\/10.1016\/j.bcp.2015.09.015","journal-title":"Biochem Pharmacol"},{"key":"4541_CR248","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20815-1","volume":"8","author":"I Patik","year":"2018","unstructured":"Patik I, Sz\u00e9kely V, N\u00e9met O, Szepesi \u00c1, Kucsma N, V\u00e1rady G, Szak\u00e1cs G, Bakos \u00c9, \u00d6zvegy-Laczka C (2018) Identification of novel cell-impermeant fluorescent substrates for testing the function and drug interaction of organic anion-transporting polypeptides, OATP1B1\/1B3 and 2B1. Sci Rep 8:2630-. https:\/\/doi.org\/10.1038\/s41598-018-20815-1","journal-title":"Sci Rep"},{"key":"4541_CR249","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2012.00001","author":"P Pavek","year":"2012","unstructured":"Pavek P, Stejskalova L, Krausova L, Bitman M, Vrzal R, Dvorak Z (2012) Rifampicin does not significantly affect the expression of small heterodimer partner in primary human hepatocytes. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2012.00001","journal-title":"Front Pharmacol"},{"key":"4541_CR250","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1021\/jm7015683","volume":"51","author":"JM Pedersen","year":"2008","unstructured":"Pedersen JM, Matsson P, Bergstr\u00f6m CAS, Norinder U, Hoogstraate J, Artursson P (2008) Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). J Med Chem 51:3275\u20133287. https:\/\/doi.org\/10.1021\/jm7015683","journal-title":"J Med Chem"},{"key":"4541_CR251","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/toxsci\/kft197","volume":"136","author":"JM Pedersen","year":"2013","unstructured":"Pedersen JM, Matsson P, Bergstr\u00f6m CAS, Hoogstraate J, Nor\u00e9n A, LeCluyse EL, Artursson P (2013) Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP\/ABCB11). Toxicol Sci 136:328\u2013343. https:\/\/doi.org\/10.1093\/toxsci\/kft197","journal-title":"Toxicol Sci"},{"key":"4541_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2019.104595","volume":"61","author":"SL Penman","year":"2019","unstructured":"Penman SL, Sharma P, Aerts H, Park BK, Weaver RJ, Chadwick AE (2019) Differential toxic effects of bile acid mixtures in isolated mitochondria and physiologically relevant HepaRG cells. Toxicol in Vitro 61:104595. https:\/\/doi.org\/10.1016\/j.tiv.2019.104595","journal-title":"Toxicol in Vitro"},{"key":"4541_CR253","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2021.100325","volume":"24","author":"SI P\u00e9rez-Pineda","year":"2021","unstructured":"P\u00e9rez-Pineda SI, Bayl\u00f3n-Pacheco L, Esp\u00edritu-Gordillo P, Tsutsumi V, Rosales-Encina JL (2021) Effect of bile acids on the expression of MRP3 and MRP4: an in vitro study in HepG2 cell line. Ann Hepatol 24:100325. https:\/\/doi.org\/10.1016\/j.aohep.2021.100325","journal-title":"Ann Hepatol"},{"key":"4541_CR254","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/ETC.4505","volume":"38","author":"EJ Perkins","year":"2019","unstructured":"Perkins EJ, Ashauer R, Burgoon L, Conolly R, Landesmann B, Mackay C, Murphy CA, Pollesch N, Wheeler JR, Zupanic A, Scholz S (2019) Building and applying quantitative adverse outcome pathway models for chemical hazard and risk assessment. Environ Toxicol Chem 38:1850. https:\/\/doi.org\/10.1002\/ETC.4505","journal-title":"Environ Toxicol Chem"},{"key":"4541_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2021.112664","volume":"158","author":"PD Petrov","year":"2021","unstructured":"Petrov PD, Soluyanova P, S\u00e1nchez-Campos S, Castell JV, Jover R (2021) Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: role of NRF2 and FXR pathways. Food Chem Toxicol 158:112664. https:\/\/doi.org\/10.1016\/j.fct.2021.112664","journal-title":"Food Chem Toxicol"},{"key":"4541_CR256","first-page":"205","volume":"48","author":"MJ Phillips","year":"1983","unstructured":"Phillips MJ, Oshio C, Miyairi M, Smith CR (1983) Intrahepatic cholestasis as a canalicular motility disorder. Evidence using cytochalasin. Lab Invest 48:205\u2013211","journal-title":"Lab Invest"},{"key":"4541_CR257","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2217\/BMM-2020-0691","volume":"15","author":"A Pieters","year":"2021","unstructured":"Pieters A, Gijbels E, Cogliati B, Annaert P, Devisscher L, Vinken M (2021) Biomarkers of cholestasis. Biomark Med 15:437\u2013454. https:\/\/doi.org\/10.2217\/BMM-2020-0691","journal-title":"Biomark Med"},{"key":"4541_CR258","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jhep.2010.12.004","volume":"54","author":"TWH Pols","year":"2011","unstructured":"Pols TWH, Noriega LG, Nomura M, Auwerx J, Schoonjans K (2011) The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol 54:1263\u20131272. https:\/\/doi.org\/10.1016\/j.jhep.2010.12.004","journal-title":"J Hepatol"},{"key":"4541_CR259","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1172\/jci112662","volume":"78","author":"HMG Princen","year":"1986","unstructured":"Princen HMG, Huijsmans CMG, Kuipers F, Vonk RJ, Kempen HJ (1986) Ketoconazole blocks bile acid synthesis in hepatocyte monolayer cultures and in vivo in rat by inhibiting cholesterol 7 alpha-hydroxylase. J Clin Invest 78:1064. https:\/\/doi.org\/10.1172\/jci112662","journal-title":"J Clin Invest"},{"key":"4541_CR260","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1042\/bj2750501","volume":"275","author":"HMG Princen","year":"1991","unstructured":"Princen HMG, Meijer P, Wolthers BG, Vonk RJ, Kuipers F (1991) Cyclosporin A blocks bile acid synthesis in cultured hepatocytes by specific inhibition of chenodeoxycholic acid synthesis. Biochem J 275:501. https:\/\/doi.org\/10.1042\/bj2750501","journal-title":"Biochem J"},{"key":"4541_CR261","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2021.105133","volume":"73","author":"S Proen\u00e7a","year":"2021","unstructured":"Proen\u00e7a S, Escher BI, Fischer FC, Fisher C, Gr\u00e9goire S, Hewitt NJ, Nicol B, Paini A, Kramer NI (2021) Effective exposure of chemicals in in vitro cell systems: a review of chemical distribution models. Toxicol in Vitro 73:105133. https:\/\/doi.org\/10.1016\/j.tiv.2021.105133","journal-title":"Toxicol in Vitro"},{"key":"4541_CR262","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1172\/jci15387","volume":"110","author":"CR Pullinger","year":"2002","unstructured":"Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, Verhagen A, Rivera CR, Mulvihill SJ, Malloy MJ, Kane JP (2002) Human cholesterol 7\u03b1-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 110:109. https:\/\/doi.org\/10.1172\/jci15387","journal-title":"J Clin Invest"},{"key":"4541_CR263","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/aivt.2015.0014","volume":"1","author":"L Qiu","year":"2015","unstructured":"Qiu L, Finley J, Taimi M, Aleo MD, Strock C, Gilbert J, Qin S, Will Y (2015) High-content imaging in human and rat hepatocytes using the fluorescent dyes CLF and CMFDA is not specific enough to assess BSEP\/Bsep and\/or MRP2\/Mrp2 inhibition by cholestatic drugs. Appl in Vitro Toxicol 1:198\u2013212. https:\/\/doi.org\/10.1089\/aivt.2015.0014","journal-title":"Appl in Vitro Toxicol"},{"key":"4541_CR264","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00204-017-2079-6","volume":"92","author":"T Ramirez","year":"2017","unstructured":"Ramirez T, Strigun A, Verlohner A, Huener HA, Peter E, Herold M, Bordag N, Mellert W, Walk T, Spitzer M, Jiang X, Sperber S, Hofmann T, Hartung T, Kamp H, van Ravenzwaay B (2017) Prediction of liver toxicity and mode of action using metabolomics in vitro in HepG2 cells. Arch Toxicol 92:893. https:\/\/doi.org\/10.1007\/s00204-017-2079-6","journal-title":"Arch Toxicol"},{"key":"4541_CR265","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10050674\/S1","author":"MJ Reiniers","year":"2021","unstructured":"Reiniers MJ, de Haan LR, Reeskamp LF, Broekgaarden M, van Golen RF, Heger M (2021) Analysis and optimization of conditions for the use of 2\u2032,7\u2032-dichlorofluorescein diacetate in cultured hepatocytes. Antioxidants. https:\/\/doi.org\/10.3390\/antiox10050674\/S1","journal-title":"Antioxidants"},{"key":"4541_CR266","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/CPT.1458","volume":"106","author":"AJS Ribeiro","year":"2019","unstructured":"Ribeiro AJS, Yang X, Patel V, Madabushi R, Strauss DG (2019) Liver microphysiological systems for predicting and evaluating drug effects. Clin Pharmacol Ther 106:139. https:\/\/doi.org\/10.1002\/CPT.1458","journal-title":"Clin Pharmacol Ther"},{"key":"4541_CR267","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1021\/tx5000393","volume":"27","author":"T Ritschel","year":"2014","unstructured":"Ritschel T, Hermans SMA, Schreurs M, Van Den Heuvel JJMW, Koenderink JB, Greupink R, Russel FGM (2014) In silico identification and in vitro validation of potential cholestatic compounds through 3D ligand-based pharmacophore modeling of BSEP inhibitors. Chem Res Toxicol 27:873\u2013881. https:\/\/doi.org\/10.1021\/tx5000393","journal-title":"Chem Res Toxicol"},{"key":"4541_CR268","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1053\/jhep.2003.50331","volume":"38","author":"M Rius","year":"2003","unstructured":"Rius M, Nies AT, Hummel-Eisenbeiss J, Jedlitschky G, Keppler D (2003) Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38:374\u2013384. https:\/\/doi.org\/10.1053\/jhep.2003.50331","journal-title":"Hepatology"},{"key":"4541_CR269","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/S00204-018-2214-Z","volume":"92","author":"RM Rodrigues","year":"2018","unstructured":"Rodrigues RM, Kollipara L, Chaudhari U, Sachinidis A, Zahedi RP, Sickmann A, Kopp-Schneider A, Jiang X, Keun H, Hengstler J, Oorts M, Annaert P, Hoeben E, Gijbels E, De Kock J, Vanhaecke T, Rogiers V, Vinken M (2018) Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures. Arch Toxicol 92:1939\u20131952. https:\/\/doi.org\/10.1007\/S00204-018-2214-Z","journal-title":"Arch Toxicol"},{"key":"4541_CR270","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1021\/acs.jcim.3c00945","volume":"64","author":"P Rodr\u00edguez-Belenguer","year":"2024","unstructured":"Rodr\u00edguez-Belenguer P, Mangas-Sanjuan V, Soria-Olivas E, Pastor M (2024) Integrating mechanistic and toxicokinetic information in predictive models of cholestasis. J Chem Inf Model 64:2775\u20132788. https:\/\/doi.org\/10.1021\/acs.jcim.3c00945","journal-title":"J Chem Inf Model"},{"key":"4541_CR271","doi-asserted-by":"publisher","DOI":"10.1186\/S13321-024-00943-9","volume":"17","author":"P Rodr\u00edguez-Belenguer","year":"2025","unstructured":"Rodr\u00edguez-Belenguer P, Soria-Olivas E, Pastor M (2025) StreamChol: a web-based application for predicting cholestasis. J Cheminform 17:9. https:\/\/doi.org\/10.1186\/S13321-024-00943-9","journal-title":"J Cheminform"},{"key":"4541_CR272","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1006\/faat.1997.2309","volume":"37","author":"MG Roma","year":"1997","unstructured":"Roma MG, Orsler DJ, Coleman R (1997) Canalicular retention as an in vitro assay of tight junctional permeability in isolated hepatocyte couplets: effects of protein kinase modulation and cholestatic agents. Fundam Appl Toxicol 37:71\u201381. https:\/\/doi.org\/10.1006\/faat.1997.2309","journal-title":"Fundam Appl Toxicol"},{"key":"4541_CR273","doi-asserted-by":"publisher","first-page":"6863","DOI":"10.3390\/ijms25136863\/s1","volume":"25","author":"S Rom\u00e1n-Sag\u00fcillo","year":"2024","unstructured":"Rom\u00e1n-Sag\u00fcillo S, Qui\u00f1ones Castro R, Ju\u00e1rez-Fern\u00e1ndez M, Soluyanova P, Stephens C, Robles-D\u00edaz M, Jorquera Plaza F, Gonz\u00e1lez-Gallego J, Mart\u00ednez-Fl\u00f3rez S, Garc\u00eda-Mediavilla MV, Nistal E, Jover R, S\u00e1nchez-Campos S (2024) Idiosyncratic drug-induced liver injury and amoxicillin\u2013clavulanate: spotlight on gut microbiota, fecal metabolome and bile acid profile in patients. Int J Mol Sci 25:6863. https:\/\/doi.org\/10.3390\/ijms25136863\/s1","journal-title":"Int J Mol Sci"},{"key":"4541_CR274","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.3390\/ijms231911428","volume":"23","author":"J Rosell\u00f3-Catafau","year":"2022","unstructured":"Rosell\u00f3-Catafau J, Messina A, Duclos-Vall\u00e9e J-C, Donato MT, Gallego-Ferrer G, Tolosa L (2022) In vitro models for studying chronic drug-induced liver injury. Int J Mol Sci 23:11428. https:\/\/doi.org\/10.3390\/ijms231911428","journal-title":"Int J Mol Sci"},{"key":"4541_CR275","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/ANNUREV.BIOCHEM.72.121801.161712","volume":"72","author":"DW Russell","year":"2003","unstructured":"Russell DW (2003) The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72:137\u2013174. https:\/\/doi.org\/10.1146\/ANNUREV.BIOCHEM.72.121801.161712","journal-title":"Annu Rev Biochem"},{"key":"4541_CR276","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1002\/hep.31999","volume":"74","author":"I Rusyn","year":"2021","unstructured":"Rusyn I, Arzuaga X, Cattley RC, Corton JC, Ferguson SS, Godoy P, Guyton KZ, Kaplowitz N, Khetani SR, Roberts RA, Roth RA, Smith MT (2021) Key characteristics of human hepatotoxicants as a basis for identification and characterization of the causes of liver toxicity. Hepatology 74:3486. https:\/\/doi.org\/10.1002\/hep.31999","journal-title":"Hepatology"},{"key":"4541_CR277","doi-asserted-by":"publisher","DOI":"10.1016\/J.TIV.2019.104619","volume":"61","author":"Y Sakai","year":"2019","unstructured":"Sakai Y, Okumura H, Iwao T, Watashi K, Ito K, Matsunaga T (2019) Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration. Toxicol in Vitro 61:104619. https:\/\/doi.org\/10.1016\/J.TIV.2019.104619","journal-title":"Toxicol in Vitro"},{"key":"4541_CR278","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1248\/bpb.b19-00249","volume":"42","author":"S Sanoh","year":"2019","unstructured":"Sanoh S, Tamura Y, Fujino C, Sugahara G, Yoshizane Y, Yanagi A, Kisoh K, Ishida Y, Tateno C, Ohta S, Kotake Y (2019) Changes in bile acid concentrations after administration of ketoconazole or rifampicin to chimeric mice with humanized liver. Biol Pharm Bull 42:1366\u20131375. https:\/\/doi.org\/10.1248\/bpb.b19-00249","journal-title":"Biol Pharm Bull"},{"key":"4541_CR279","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1147495","volume":"14","author":"C Saran","year":"2023","unstructured":"Saran C, Ho H, Honkakoski P, Brouwer KLR (2023) Effect of mTOR inhibitors on sodium taurocholate cotransporting polypeptide (NTCP) function in vitro. Front Pharmacol 14:1147495. https:\/\/doi.org\/10.3389\/fphar.2023.1147495","journal-title":"Front Pharmacol"},{"key":"4541_CR280","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1124\/molpharm.123.000725","volume":"105","author":"AM Sch\u00e4fer","year":"2024","unstructured":"Sch\u00e4fer AM, Rysz MA, Sch\u00e4deli J, H\u00fcbscher M, Khosravi H, Fehr M, Seibert I, Potterat O, Smie\u0161ko M, Meyer zu Schwabedissen HE (2024) St. John\u2019s wort formulations induce rat CYP3A23-3A1 independent of their hyperforin content. Mol Pharm 105:14\u201322. https:\/\/doi.org\/10.1124\/molpharm.123.000725","journal-title":"Mol Pharm"},{"key":"4541_CR281","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2023.108082","author":"S Schmeisser","year":"2023","unstructured":"Schmeisser S, Miccoli A, von Bergen M, Berggren E, Braeuning A, Busch W, Desaintes C, Gourmelon A, Grafstr\u00f6m R, Harrill J, Hartung T, Herzler M, Kass G, Kleinstreuer N, Leist M, Luijten M, Marx-Stoelting P, Poetz O, van Ravenzwaay B, Roggeband R, Rogiers V, Roth A, Sanders P, Thomas RS, Marie Vinggaard A, Vinken M, van de Water B, Luch A, Tralau T (2023) New approach methodologies in human regulatory toxicology\u2014Not if, but how and when! Environ Int. https:\/\/doi.org\/10.1016\/j.envint.2023.108082","journal-title":"Environ Int"},{"key":"4541_CR282","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00204-016-1805-9","volume":"91","author":"BZ Schmidt","year":"2016","unstructured":"Schmidt BZ, Lehmann M, Gutbier S, Nembo E, Noel S, Smirnova L, Forsby A, Hescheler J, Avci HX, Hartung T, Leist M, Kobol\u00e1k J, Dinny\u00e9s A (2016) In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities. Arch Toxicol 91:1\u201333. https:\/\/doi.org\/10.1007\/s00204-016-1805-9","journal-title":"Arch Toxicol"},{"key":"4541_CR283","doi-asserted-by":"publisher","first-page":"G1259","DOI":"10.1152\/AJPGI.00177.2009","volume":"297","author":"CM Schonhoff","year":"2009","unstructured":"Schonhoff CM, Yamazaki A, Hohenester S, Webster CRL, Bouscarel B, Anwer MS (2009) PKC\u03b5-dependent and -independent effects of taurolithocholate on PI3K\/PKB pathway and taurocholate uptake in HuH-NTCP cell line. Am J Physiol Gastrointest Liver Physiol 297:G1259. https:\/\/doi.org\/10.1152\/AJPGI.00177.2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4541_CR284","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/S00204-024-03893-1","volume":"99","author":"L Sch\u00fcrmeyer","year":"2024","unstructured":"Sch\u00fcrmeyer L, Peng C, Albrecht W, Brecklinghaus T, Baur P, Hengstler JG, Schorning K (2024) Design of optimal concentrations for in vitro cytotoxicity experiments. Arch Toxicol 99:357. https:\/\/doi.org\/10.1007\/S00204-024-03893-1","journal-title":"Arch Toxicol"},{"key":"4541_CR285","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1007\/S00204-019-02502-W","volume":"93","author":"B Seeger","year":"2019","unstructured":"Seeger B, Mentz A, Knebel C, Schmidt F, Bednarz H, Niehaus K, Albaum S, Kalinowski J, Noll T, Steinberg P, Marx-Stoelting P, Heise T (2019) Assessment of mixture toxicity of (tri)azoles and their hepatotoxic effects in vitro by means of omics technologies. Arch Toxicol 93:2321\u20132333. https:\/\/doi.org\/10.1007\/S00204-019-02502-W","journal-title":"Arch Toxicol"},{"key":"4541_CR286","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/13543776.2018.1459569","volume":"28","author":"V Sepe","year":"2018","unstructured":"Sepe V, Distrutti E, Fiorucci S, Zampella A (2018) Farnesoid X receptor modulators 2014-present: a patent review. Expert Opin Ther Pat 28:351\u2013364. https:\/\/doi.org\/10.1080\/13543776.2018.1459569","journal-title":"Expert Opin Ther Pat"},{"key":"4541_CR287","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1053\/J.GASTRO.2013.02.004","volume":"144","author":"KDR Setchell","year":"2013","unstructured":"Setchell KDR, Heubi JE, Shah S, Lavine JE, Suskind D, Al-Edreesi M, Potter C, Russell DW, O\u2019Connell NC, Wolfe B, Jha P, Zhang W, Bove KE, Knisely AS, Hofmann AF, Rosenthal P, Bull LN (2013) Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency. Gastroenterology 144:945. https:\/\/doi.org\/10.1053\/J.GASTRO.2013.02.004","journal-title":"Gastroenterology"},{"key":"4541_CR288","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/toxsci\/kfu122","volume":"141","author":"A Sharanek","year":"2014","unstructured":"Sharanek A, Azzi PB-E, Al-Attrache H, Savary CC, Humbert L, Rainteau D, Guguen-Guillouzo C, Guillouzo A (2014) Different dose-dependent mechanisms are involved in early cyclosporine A-induced cholestatic effects in HepaRG cells. Toxicol Sci 141:244\u2013253. https:\/\/doi.org\/10.1093\/toxsci\/kfu122","journal-title":"Toxicol Sci"},{"key":"4541_CR289","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/toxsci\/kfv155","volume":"147","author":"A Sharanek","year":"2015","unstructured":"Sharanek A, Burban A, Humbert L, Bachour-El Azzi P, Felix-Gomes N, Rainteau D, Guillouzo A (2015) Cellular accumulation and toxic effects of bile acids in cyclosporine A-treated HepaRG hepatocytes. Toxicol Sci 147:573\u2013587. https:\/\/doi.org\/10.1093\/toxsci\/kfv155","journal-title":"Toxicol Sci"},{"key":"4541_CR290","doi-asserted-by":"publisher","DOI":"10.1038\/srep24709","volume":"6","author":"A Sharanek","year":"2016","unstructured":"Sharanek A, Burban A, Burbank M, Le Guevel R, Li R, Guillouzo A, Guguen-Guillouzo C (2016) Rho-kinase\/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs. Sci Rep 6:24709. https:\/\/doi.org\/10.1038\/srep24709","journal-title":"Sci Rep"},{"key":"4541_CR291","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1124\/dmd.117.077420","volume":"45","author":"A Sharanek","year":"2017","unstructured":"Sharanek A, Burban A, Humbert L, Guguen-Guillouzo C, Rainteau D, Guillouzo A (2017) Progressive and preferential cellular accumulation of hydrophobic bile acids induced by cholestatic drugs is associated with inhibition of their amidation and sulfation. Drug Metab Dispos 45:1292\u20131303. https:\/\/doi.org\/10.1124\/dmd.117.077420","journal-title":"Drug Metab Dispos"},{"key":"4541_CR292","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tiv.2019.03.015","volume":"58","author":"A Sharanek","year":"2019","unstructured":"Sharanek A, Burban A, Ciriaci N, Guillouzo A (2019) Pro-inflammatory cytokines enhance dilatation of bile canaliculi caused by cholestatic antibiotics. Toxicol in Vitro 58:51\u201359. https:\/\/doi.org\/10.1016\/j.tiv.2019.03.015","journal-title":"Toxicol in Vitro"},{"key":"4541_CR293","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","volume":"160","author":"T Shinozawa","year":"2021","unstructured":"Shinozawa T, Kimura M, Cai Y, Saiki N, Yoneyama Y, Ouchi R, Koike H, Maezawa M, Zhang RR, Dunn A, Ferguson A, Togo S, Lewis K, Thompson WL, Asai A, Takebe T (2021) High-fidelity drug-induced liver injury screen using human pluripotent stem cell\u2013derived organoids. Gastroenterology 160:831-846.e10. https:\/\/doi.org\/10.1053\/j.gastro.2020.10.002","journal-title":"Gastroenterology"},{"key":"4541_CR294","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2133\/dmpk.DMPK-10-RV-094","volume":"26","author":"Y Shitara","year":"2011","unstructured":"Shitara Y (2011) Clinical importance of OATP1B1 and OATP1B3 in drugdrug interactions. Drug Metab Pharmacokinet 26:220\u2013227. https:\/\/doi.org\/10.2133\/dmpk.DMPK-10-RV-094","journal-title":"Drug Metab Pharmacokinet"},{"key":"4541_CR295","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1124\/jpet.102.041921","volume":"304","author":"Y Shitara","year":"2003","unstructured":"Shitara Y, Itoh T, Sato H, Li AP, Sugiyama Y (2003) Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A. J Pharm Exp Ther 304:610\u2013616. https:\/\/doi.org\/10.1124\/jpet.102.041921","journal-title":"J Pharm Exp Ther"},{"key":"4541_CR296","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/s0076-6879(05)00022-4","volume":"400","author":"EM Shonsey","year":"2005","unstructured":"Shonsey EM, Sfakianos M, Johnson M, He D, Falany CN, Falany J, Merkler DJ, Barnes S (2005) Bile acid Coenzyme A: Amino acid N-acyltransferase in the amino acid conjugation of bile acids. Methods Enzymol 400:374\u2013394. https:\/\/doi.org\/10.1016\/s0076-6879(05)00022-4","journal-title":"Methods Enzymol"},{"key":"4541_CR297","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.3748\/wjg.v12.i29.4640","volume":"12","author":"EC Siljevik Ellis","year":"2006","unstructured":"Siljevik Ellis EC (2006) Suppression of bile acid synthesis by thyroid hormone in primary human hepatocytes. World J Gastroenterol 12:4640\u20134645. https:\/\/doi.org\/10.3748\/wjg.v12.i29.4640","journal-title":"World J Gastroenterol"},{"key":"4541_CR298","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116500","volume":"229","author":"T Smutny","year":"2024","unstructured":"Smutny T, Smutna L, Lochman L, Kamaraj R, Kucera R, Pavek P (2024) Rifampicin and its derivatives: stability, disposition, and affinity towards pregnane X receptor employing 2D and 3D primary human hepatocytes. Biochem Pharmacol 229:116500. https:\/\/doi.org\/10.1016\/j.bcp.2024.116500","journal-title":"Biochem Pharmacol"},{"key":"4541_CR299","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1039\/c2tx20051a","volume":"2","author":"VY Soldatow","year":"2013","unstructured":"Soldatow VY, Lecluyse EL, Griffith LG, Rusyn I (2013) In vitro models for liver toxicity testing. Toxicol Res 2:23\u201339. https:\/\/doi.org\/10.1039\/c2tx20051a","journal-title":"Toxicol Res"},{"key":"4541_CR300","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/BF02473272","volume":"106","author":"JY Song","year":"1996","unstructured":"Song JY, Van Marle J, Van Noorden CJF, Frederiks WM (1996) Disturbed structural interactions between microfilaments and tight junctions in rat hepatocytes during extrahepatic cholestasis induced by common bile duct ligation. Histochem Cell Biol 106:573\u2013580. https:\/\/doi.org\/10.1007\/BF02473272","journal-title":"Histochem Cell Biol"},{"key":"4541_CR301","doi-asserted-by":"publisher","first-page":"13801","DOI":"10.1073\/PNAS.212494599;WGROUP:STRING:PUBLICATION","volume":"99","author":"J Sonoda","year":"2002","unstructured":"Sonoda J, Xie W, Rosenfeld JM, Barwick JL, Guzelian PS, Evans RM (2002) Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci U S A 99:13801\u201313806. https:\/\/doi.org\/10.1073\/PNAS.212494599;WGROUP:STRING:PUBLICATION","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4541_CR302","doi-asserted-by":"publisher","DOI":"10.1242\/bio.058606","volume":"10","author":"R Sonoi","year":"2021","unstructured":"Sonoi R, Hagihara Y (2021) Tight junction stabilization prevents HepaRG cell death in drug-induced intrahepatic cholestasis. Biol Open 10:058606. https:\/\/doi.org\/10.1242\/bio.058606","journal-title":"Biol Open"},{"key":"4541_CR303","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.960","volume":"10","author":"R Sonoi","year":"2022","unstructured":"Sonoi R, Hagihara Y (2022) Quantitative understanding of HepaRG cells during drug-induced intrahepatic cholestasis through changes in bile canaliculi dynamics. Pharmacol Res Perspect 10:e00960. https:\/\/doi.org\/10.1002\/prp2.960","journal-title":"Pharmacol Res Perspect"},{"key":"4541_CR304","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1073\/pnas.051551698","volume":"98","author":"JL Staudinger","year":"2001","unstructured":"Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, Liu Y, Klaassen CD, Brown KK, Reinhard J, Willson TM, Koller BH, Kliewer SA (2001) The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A 98:3369\u20133374. https:\/\/doi.org\/10.1073\/pnas.051551698","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4541_CR305","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/03602532.2012.748793","volume":"45","author":"JL Staudinger","year":"2013","unstructured":"Staudinger JL, Woody S, Sun M, Cui W (2013) Nuclear-receptor-mediated regulation of drug-and bile-acid-transporter proteins in gut and liver. Drug Metab Rev 45:48\u201359. https:\/\/doi.org\/10.3109\/03602532.2012.748793","journal-title":"Drug Metab Rev"},{"key":"4541_CR306","doi-asserted-by":"publisher","first-page":"15605","DOI":"10.1074\/jbc.C000015200","volume":"275","author":"SJ Steinberg","year":"2000","unstructured":"Steinberg SJ, Mihalik SJ, Kim DG, Cuebas DA, Watkins PA (2000) The human liver-specific homolog of very long-chain acyl-CoA synthetase is cholate:CoA ligase. J Biol Chem 275:15605\u201315608. https:\/\/doi.org\/10.1074\/jbc.C000015200","journal-title":"J Biol Chem"},{"key":"4541_CR307","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/B978-0-12-387817-5.00007-8","volume":"28","author":"B Stieger","year":"2013","unstructured":"Stieger B, Kullak-Ublick GA (2013) Role of membrane transport in hepatotoxicity and pathogenesis of drug-induced cholestasis. Drug-Induced Liver Disease 28:123\u2013133. https:\/\/doi.org\/10.1016\/B978-0-12-387817-5.00007-8","journal-title":"Drug-Induced Liver Disease"},{"key":"4541_CR308","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1017\/err.2025.1","volume":"16","author":"K Stoykova","year":"2025","unstructured":"Stoykova K (2025) Towards non-animal testing in European regulatory toxicology: an introduction to the REACH framework and challenges in implementing the 3Rs. Eur J Risk Regul 16:985\u20131016. https:\/\/doi.org\/10.1017\/err.2025.1","journal-title":"Eur J Risk Regul"},{"key":"4541_CR309","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1194\/jlr.m064428","volume":"57","author":"NA Styles","year":"2016","unstructured":"Styles NA, Shonsey EM, Falany JL, Guidry AL, Barnes S, Falany CN (2016) Carboxy-terminal mutations of bile acid CoA:N-acyltransferase alter activity and substrate specificity. J Lipid Res 57:1133. https:\/\/doi.org\/10.1194\/jlr.m064428","journal-title":"J Lipid Res"},{"key":"4541_CR310","doi-asserted-by":"publisher","first-page":"1858289","DOI":"10.3389\/fimmu.2026.1858289\/","volume":"17","author":"JH Sung","year":"2026","unstructured":"Sung JH, Kim R (2026) In vitro models of the gut-liver axis: what we\u2019ve learned and what remains to be built. Front Immunol 17:1858289. https:\/\/doi.org\/10.3389\/fimmu.2026.1858289\/","journal-title":"Front Immunol"},{"key":"4541_CR311","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1073\/PNAS.89.9.3741","volume":"89","author":"SKH Swanson","year":"1992","unstructured":"Swanson SKH, Born T, Zydowsky LD, Cho H, Chang HY, Walsh CT, Rusnak F (1992) Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B. Proc Natl Acad Sci U S A 89:3741. https:\/\/doi.org\/10.1073\/PNAS.89.9.3741","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4541_CR312","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/03602530903491881","volume":"42","author":"B Swift","year":"2010","unstructured":"Swift B, Pfeifer ND, Brouwer KLR (2010) Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 42:446\u2013471. https:\/\/doi.org\/10.3109\/03602530903491881","journal-title":"Drug Metab Rev"},{"key":"4541_CR313","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059432","volume":"8","author":"M Szabo","year":"2013","unstructured":"Szabo M, Veres Z, Baranyai Z, Jakab F, Jemnitz K (2013) Comparison of human hepatoma HepaRG cells with human and rat hepatocytes in uptake transport assays in order to predict a risk of drug induced hepatotoxicity. PLoS ONE 8:e59432. https:\/\/doi.org\/10.1371\/journal.pone.0059432","journal-title":"PLoS ONE"},{"key":"4541_CR314","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105395","volume":"151","author":"V Sz\u00e9kely","year":"2020","unstructured":"Sz\u00e9kely V, Patik I, Ungv\u00e1ri O, Telbisz \u00c1, Szak\u00e1cs G, Bakos \u00c9, \u00d6zvegy-Laczka C (2020) Fluorescent probes for the dual investigation of MRP2 and OATP1B1 function and drug interactions. Eur J Pharm Sci 151:105395. https:\/\/doi.org\/10.1016\/j.ejps.2020.105395","journal-title":"Eur J Pharm Sci"},{"key":"4541_CR315","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22095038","volume":"22","author":"A Tabernilla","year":"2021","unstructured":"Tabernilla A, Rodrigues BDS, Pieters A, Caufriez A, Leroy K, Van Campenhout R, Cooreman A, Gomes AR, Arnesdotter E, Gijbels E, Vinken M (2021) In vitro liver toxicity testing of chemicals: a pragmatic approach. Int J Mol Sci 22:5038. https:\/\/doi.org\/10.3390\/ijms22095038","journal-title":"Int J Mol Sci"},{"key":"4541_CR316","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3892\/IJMM.2015.2233\/ABSTRACT","volume":"36","author":"YM Tang","year":"2015","unstructured":"Tang YM, Wang JP, Bao WM, Yang JH, Ma LK, Yang J, Chen H, Xu Y, Yang LH, Li W, Zhu YP, Bin Cheng J (2015) Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosis. Int J Mol Med 36:377\u2013385. https:\/\/doi.org\/10.3892\/IJMM.2015.2233\/ABSTRACT","journal-title":"Int J Mol Med"},{"key":"4541_CR317","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1093\/BIOLRE\/IOAF184","volume":"113","author":"M Tang","year":"2025","unstructured":"Tang M, Luo M, Zhang L, Xiong L, Gong X, Zhou X, Yang J, Wang P, Zhao Z, Wu S, Xing SS, Cai J, Yang X (2025) Multi-omics characterization of autophagy-related molecular features in intrahepatic cholestasis of pregnancy. Biol Reprod 113:1510\u20131522. https:\/\/doi.org\/10.1093\/BIOLRE\/IOAF184","journal-title":"Biol Reprod"},{"key":"4541_CR318","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/00005176-198406000-00016","volume":"3","author":"Y Tazawa","year":"1984","unstructured":"Tazawa Y, Yamada M, Nakagawa M, Konno T, Tada K (1984) Serum bile acid patterns determined by an enzymatic method and high-performance liquid chromatography in young infants with cholestasis. J Pediatr Gastroenterol Nutr 3:394\u2013401. https:\/\/doi.org\/10.1097\/00005176-198406000-00016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4541_CR319","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/sj.bjp.0707235","volume":"151","author":"S Teng","year":"2007","unstructured":"Teng S, Piquette-Miller M (2007) Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. Br J Pharmacol 151:367\u2013376. https:\/\/doi.org\/10.1038\/sj.bjp.0707235","journal-title":"Br J Pharmacol"},{"key":"4541_CR320","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0300-483X(92)90069-Q","volume":"73","author":"N Thibault","year":"1992","unstructured":"Thibault N, Claude JR, Ballet F (1992) Actin filament alteration as a potential marker for cholestasis: a study in isolated rat hepatocyte couplets. Toxicology 73:269\u2013279. https:\/\/doi.org\/10.1016\/0300-483X(92)90069-Q","journal-title":"Toxicology"},{"key":"4541_CR321","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1124\/dmd.106.013615","volume":"35","author":"A Treiber","year":"2007","unstructured":"Treiber A, Schneiter R, H\u00e4usler S, Stieger B (2007) Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. Drug Metab Dispos 35:1400\u20131407. https:\/\/doi.org\/10.1124\/dmd.106.013615","journal-title":"Drug Metab Dispos"},{"key":"4541_CR322","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022094","volume":"6","author":"J Trottier","year":"2011","unstructured":"Trottier J, Bia\u0142ek A, Caron P, Straka RJ, Milkiewicz P, Barbier O (2011) Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting. PLoS ONE 6:e22094. https:\/\/doi.org\/10.1371\/journal.pone.0022094","journal-title":"PLoS ONE"},{"key":"4541_CR323","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.dld.2011.10.025","volume":"44","author":"J Trottier","year":"2012","unstructured":"Trottier J, Bia\u0142ek A, Caron P, Straka RJ, Heathcote J, Milkiewicz P, Barbier O (2012) Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study. Dig Liver Dis 44:303\u2013310. https:\/\/doi.org\/10.1016\/j.dld.2011.10.025","journal-title":"Dig Liver Dis"},{"key":"4541_CR324","doi-asserted-by":"publisher","unstructured":"J. Trottier, A.-A. Lavoie, M. Verreault, E. Wunsch, R.J. Straka, N. Ghonem, P. Milkiewicz, O. Barbier, Glucuronidation: The last defensive line against bile acid toxicity during cholestasis, BioRxiv (2025) 2025.08.23.671933. https:\/\/doi.org\/10.1101\/2025.08.23.671933.","DOI":"10.1101\/2025.08.23.671933"},{"key":"4541_CR325","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100648R","volume":"35","author":"O Ungv\u00e1ri","year":"2021","unstructured":"Ungv\u00e1ri O, Kir\u00e1ly L, Bakos \u00c9, \u00d6zvegy-Laczka C (2021) 8-acetoxy-trisulfopyrene as the first activatable fluorogenic probe for add-and-read assessment of organic anion-transporting polypeptides, OATP1B1, OATP1B3, and OATP2B1. FASEB J 35:e21863. https:\/\/doi.org\/10.1096\/fj.202100648R","journal-title":"FASEB J"},{"key":"4541_CR326","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-4939-9420-5_4","volume":"2019","author":"P Van Brantegem","year":"1981","unstructured":"Van Brantegem P, Deferm N, Qi B, De Vocht T, Annaert P (1981) Vesicle- and hepatocyte-based assays for identification of drug candidates inhibiting BSEP function. Methods Mol Biol 2019:55\u201373. https:\/\/doi.org\/10.1007\/978-1-4939-9420-5_4","journal-title":"Methods Mol Biol"},{"key":"4541_CR327","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1021\/tx4004165","volume":"27","author":"WFPM Van den Hof","year":"2014","unstructured":"Van den Hof WFPM, Coonen MLJ, van Herwijnen M, Brauers K, Wodzig WKWH, van Delft JHM, Kleinjans JCS (2014) Classification of hepatotoxicants using HepG2 cells: a proof of principle study. Chem Res Toxicol 27:433\u2013442. https:\/\/doi.org\/10.1021\/tx4004165","journal-title":"Chem Res Toxicol"},{"key":"4541_CR328","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tiv.2014.12.016","volume":"29","author":"WFPM Van den Hof","year":"2015","unstructured":"Van den Hof WFPM, Ruiz-Aracama A, Van Summeren A, Jennen DGJ, Gaj S, Coonen MLJ, Brauers K, Wodzig WKWH, van Delft JHM, Kleinjans JCS (2015) Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol in Vitro 29:489\u2013501. https:\/\/doi.org\/10.1016\/j.tiv.2014.12.016","journal-title":"Toxicol in Vitro"},{"key":"4541_CR329","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.tiv.2017.07.024","volume":"44","author":"WFPM Van den Hof","year":"2017","unstructured":"Van den Hof WFPM, Coonen MLJ, van Herwijnen M, Brauers K, Jennen D, Olde Damink SWM, Schaap FG, Kleinjans JCS (2017) Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis. Toxicol in Vitro 44:322\u2013329. https:\/\/doi.org\/10.1016\/j.tiv.2017.07.024","journal-title":"Toxicol in Vitro"},{"key":"4541_CR330","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2023.104465","volume":"145","author":"J van Ertvelde","year":"2023","unstructured":"van Ertvelde J, Verhoeven A, Maerten A, Cooreman A, dos Santos Rodrigues B, Sanz-Serrano J, Mihajlovic M, Tripodi I, Teunis M, Jover R, Luechtefeld T, Vanhaecke T, Jiang J, Vinken M (2023) Optimization of an adverse outcome pathway network on chemical-induced cholestasis using an artificial intelligence-assisted data collection and confidence level quantification approach. J Biomed Inform 145:104465. https:\/\/doi.org\/10.1016\/j.jbi.2023.104465","journal-title":"J Biomed Inform"},{"key":"4541_CR331","doi-asserted-by":"publisher","first-page":"964","DOI":"10.7150\/ijbs.15165","volume":"12","author":"M van Wenum","year":"2016","unstructured":"van Wenum M, Adam AAA, Hakvoort TBM, Hendriks EJ, Shevchenko V, van Gulik TM, Chamuleau RAFM, Hoekstra R (2016) Selecting cells for bioartificial liver devices and the importance of a 3D culture environment: a functional comparison between the HepaRG and C3A cell lines. Int J Biol Sci 12:964\u2013978. https:\/\/doi.org\/10.7150\/ijbs.15165","journal-title":"Int J Biol Sci"},{"key":"4541_CR332","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/S00204-016-1778-8","volume":"91","author":"S Vatakuti","year":"2017","unstructured":"Vatakuti S, Olinga P, Pennings JLA, Groothuis GMM (2017) Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach. Arch Toxicol 91:1401\u20131412. https:\/\/doi.org\/10.1007\/S00204-016-1778-8","journal-title":"Arch Toxicol"},{"key":"4541_CR333","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1124\/dmd.115.067744","volume":"44","author":"LMM Vermeer","year":"2016","unstructured":"Vermeer LMM, Isringhausen CD, Ogilvie BW, Buckley DB (2016) Evaluation of ketoconazole and its alternative clinical CYP3A4\/5 inhibitors as inhibitors of drug transporters: the in vitro effects of ketoconazole, ritonavir, clarithromycin, and itraconazole on 13 clinically-relevant drug transporters. Drug Metab Dispos 44:453\u2013459. https:\/\/doi.org\/10.1124\/dmd.115.067744","journal-title":"Drug Metab Dispos"},{"key":"4541_CR334","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/HEP.21259","volume":"44","author":"M Verreault","year":"2006","unstructured":"Verreault M, Senekeo-Effenberger K, Trottier J, Bonzo JA, B\u00e9langer J, Kaeding J, Staels B, Caron P, Tukey RH, Barbier O (2006) The liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic mice. Hepatology 44:368\u2013378. https:\/\/doi.org\/10.1002\/HEP.21259","journal-title":"Hepatology"},{"key":"4541_CR335","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00204-020-02940-x","volume":"95","author":"V Vilas-Boas","year":"2020","unstructured":"Vilas-Boas V, Vinken M (2020) Hepatotoxicity induced by nanomaterials: mechanisms and in vitro models. Arch Toxicol 95:27\u201352. https:\/\/doi.org\/10.1007\/s00204-020-02940-x","journal-title":"Arch Toxicol"},{"key":"4541_CR336","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apha.2018.08.001","volume":"85","author":"V Vilas-Boas","year":"2019","unstructured":"Vilas-Boas V, Cooreman A, Gijbels E, Van Campenhout R, Gustafson E, Ballet S, Annaert P, Cogliati B, Vinken M (2019a) Primary hepatocytes and their cultures for the testing of drug-induced liver injury. Adv Pharmacol 85:1\u201330. https:\/\/doi.org\/10.1016\/bs.apha.2018.08.001","journal-title":"Adv Pharmacol"},{"key":"4541_CR337","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1021\/acs.chemrestox.9b00148","volume":"32","author":"V Vilas-Boas","year":"2019","unstructured":"Vilas-Boas V, Gijbels E, Cooreman A, Van Campenhout R, Gustafson E, Leroy K, Vinken M (2019b) Industrial, biocide, and cosmetic chemical inducers of cholestasis. Chem Res Toxicol 32:1327\u20131334. https:\/\/doi.org\/10.1021\/acs.chemrestox.9b00148","journal-title":"Chem Res Toxicol"},{"key":"4541_CR338","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2019.105422","author":"V Vilas-Boas","year":"2020","unstructured":"Vilas-Boas V, Gijbels E, Jonckheer J, De Waele E, Vinken M (2020) Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition. Environ Int. https:\/\/doi.org\/10.1016\/j.envint.2019.105422","journal-title":"Environ Int"},{"key":"4541_CR339","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/toxsci\/kfu199","volume":"142","author":"DL Villeneuve","year":"2014","unstructured":"Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, Ottinger MA, Vergauwen L, Whelan M (2014) Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol Sci 142:312\u2013320. https:\/\/doi.org\/10.1093\/toxsci\/kfu199","journal-title":"Toxicol Sci"},{"key":"4541_CR340","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1021\/acs.chemrestox.5B00208","volume":"28","author":"M Vinken","year":"2015","unstructured":"Vinken M (2015) Adverse outcome pathways and drug-induced liver injury testing. Chem Res Toxicol 28:1391\u20131397. https:\/\/doi.org\/10.1021\/acs.chemrestox.5B00208","journal-title":"Chem Res Toxicol"},{"key":"4541_CR341","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cotox.2019.02.006","volume":"18","author":"M Vinken","year":"2019","unstructured":"Vinken M (2019) Omics-based input and output in the development and use of adverse outcome pathways. Curr Opin Toxicol 18:8\u201312. https:\/\/doi.org\/10.1016\/j.cotox.2019.02.006","journal-title":"Curr Opin Toxicol"},{"key":"4541_CR342","doi-asserted-by":"publisher","DOI":"10.1016\/j.cotox.2024.100504","volume":"40","author":"M Vinken","year":"2024","unstructured":"Vinken M (2024) Adverse outcome pathway networks as the basis for the development of new approach methodologies: liver toxicity as a case study. Curr Opin Toxicol 40:100504. https:\/\/doi.org\/10.1016\/j.cotox.2024.100504","journal-title":"Curr Opin Toxicol"},{"key":"4541_CR343","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s00204-018-2297-6","volume":"92","author":"M Vinken","year":"2018","unstructured":"Vinken M, Hengstler JG (2018) Characterization of hepatocyte-based in vitro systems for reliable toxicity testing. Arch Toxicol 92:2981\u20132986. https:\/\/doi.org\/10.1007\/s00204-018-2297-6","journal-title":"Arch Toxicol"},{"key":"4541_CR344","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/toxsci\/kft177","volume":"136","author":"M Vinken","year":"2013","unstructured":"Vinken M, Landesmann B, Goumenou M, Vinken S, Shah I, Jaeschke H, Willett C, Whelan M, Rogiers V (2013) Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury. Toxicol Sci 136:97\u2013106. https:\/\/doi.org\/10.1093\/toxsci\/kft177","journal-title":"Toxicol Sci"},{"key":"4541_CR345","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/hep.20784","volume":"42","author":"M Wagner","year":"2005","unstructured":"Wagner M, Halilbasic E, Marschall HU, Zollner G, Fickert P, Langner C, Zatloukal K, Denk H, Trauner M (2005) CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 42:420\u2013430. https:\/\/doi.org\/10.1002\/hep.20784","journal-title":"Hepatology"},{"key":"4541_CR346","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jhep.2009.05.012","volume":"51","author":"M Wagner","year":"2009","unstructured":"Wagner M, Zollner G, Trauner M (2009) New molecular insights into the mechanisms of cholestasis. J Hepatol 51:565\u2013580. https:\/\/doi.org\/10.1016\/j.jhep.2009.05.012","journal-title":"J Hepatol"},{"key":"4541_CR347","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1177\/1091581820953066","volume":"39","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wilkerson M, Li J, Zhang W, Owens A, Wright S, Hidalgo I (2020) Assessment of statin interactions with the human NTCP transporter using a novel fluorescence assay. Int J Toxicol 39:518\u2013529. https:\/\/doi.org\/10.1177\/1091581820953066","journal-title":"Int J Toxicol"},{"key":"4541_CR348","doi-asserted-by":"publisher","DOI":"10.1016\/J.TAAP.2025.117308","volume":"498","author":"W Wang","year":"2025","unstructured":"Wang W, Li L, Li X, Chen J, Wang R, Yang Q, Wang C, Meng Q (2025) \u03b2-Sitosterol protects against lithocholic acid-induced hepatotoxicity and cholestasis via farnesoid X receptor-mediated regulation of transporters and enzymes in vitro and in vivo. Toxicol Appl Pharmacol 498:117308. https:\/\/doi.org\/10.1016\/J.TAAP.2025.117308","journal-title":"Toxicol Appl Pharmacol"},{"key":"4541_CR349","doi-asserted-by":"publisher","DOI":"10.1016\/J.MTBIO.2025.101643","volume":"32","author":"M Watanabe","year":"2025","unstructured":"Watanabe M, Salvadori A, Markovic M, Sudo R, Ovsianikov A (2025) Advanced liver-on-chip model mimicking hepatic lobule with continuous microvascular network via high-definition laser patterning. Mater Today Bio 32:101643. https:\/\/doi.org\/10.1016\/J.MTBIO.2025.101643","journal-title":"Mater Today Bio"},{"key":"4541_CR350","unstructured":"S. Watanabe, M.J. Phillips, Acute phalloidin toxicity in living hepatocytes. Evidence for a possible disturbance in membrane flow and for multiple functions for actin in the liver cell, Am. J. Pathol. 122 (1986) 101. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC1888124\/ (Accessed 31 March 2026)."},{"key":"4541_CR351","doi-asserted-by":"publisher","DOI":"10.1385\/0-89603-519-0:169","author":"DJ Waxman","year":"2003","unstructured":"Waxman DJ, Chang TKH (2003) An isocratic high-performance liquid chromatography assay for CYP7A1-catalyzed cholesterol 7alpha-hydroxylation. Cytochrome P450 Prot. https:\/\/doi.org\/10.1385\/0-89603-519-0:169","journal-title":"Cytochrome P450 Prot"},{"key":"4541_CR352","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s42255-021-00366-y","volume":"3","author":"JH Weng","year":"2021","unstructured":"Weng JH, Koch PD, Luan H, Tu HC, Shimada K, Ngan I, Ventura R, Jiang R, Mitchison TJ (2021) Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation. Nat Metab 3:513. https:\/\/doi.org\/10.1038\/s42255-021-00366-y","journal-title":"Nat Metab"},{"key":"4541_CR353","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.taap.2015.01.015","volume":"283","author":"BL Woolbright","year":"2015","unstructured":"Woolbright BL, Dorko K, Antoine DJ, Clarke JI, Gholami P, Li F, Kumer SC, Schmitt TM, Forster J, Fan F, Jenkins RE, Park BK, Hagenbuch B, Olyaee M, Jaeschke H (2015a) Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis. Toxicol Appl Pharmacol 283:168\u2013177. https:\/\/doi.org\/10.1016\/j.taap.2015.01.015","journal-title":"Toxicol Appl Pharmacol"},{"key":"4541_CR354","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/bcpt.12449","volume":"118","author":"BL Woolbright","year":"2015","unstructured":"Woolbright BL, Mcgill MR, Yan H, Jaeschke H (2015b) Bile acid-induced toxicity in HepaRG cells recapitulates the response in primary human hepatocytes. Basic Clin Pharmacol Toxicol 118:160. https:\/\/doi.org\/10.1111\/bcpt.12449","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"4541_CR355","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1096\/fj.201700767R","volume":"32","author":"MR Wu","year":"2018","unstructured":"Wu MR, Liu HM, Lu CW, Shen WH, Lin IJ, Liao LW, Huang YY, Shieh MJ, Hsiao JK (2018) Organic anion-transporting polypeptide 1B3 as a dual reporter gene for fluorescence and magnetic resonance imaging. FASEB J 32:1705\u20131715. https:\/\/doi.org\/10.1096\/fj.201700767R","journal-title":"FASEB J"},{"key":"4541_CR356","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/571353","volume":"2015","author":"E Wunsch","year":"2015","unstructured":"Wunsch E, Klak M, Wasik U, Milkiewicz M, Blatkiewicz M, Urasinska E, Barbier O, Bielicki D, Bogdanos DP, Elias E, Milkiewicz P (2015) Liver expression of sulphotransferase 2A1 enzyme is impaired in patients with primary sclerosing cholangitis: lack of the response to enhanced expression of PXR. J Immunol Res 2015:571353. https:\/\/doi.org\/10.1155\/2015\/571353","journal-title":"J Immunol Res"},{"key":"4541_CR357","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1197856","volume":"14","author":"L Xi","year":"2023","unstructured":"Xi L, Shi A, Shen T, Wang G, Wei Y, Guo J (2023) Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies. Front Pharmacol 14:1197856. https:\/\/doi.org\/10.3389\/fphar.2023.1197856","journal-title":"Front Pharmacol"},{"key":"4541_CR358","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176334","volume":"966","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Wang W, Peng S, Lu Y, Du J, Cai W (2024) Farnesoid X receptor agonist tropifexor detoxifies ammonia by regulating the glutamine metabolism and urea cycles in cholestatic livers. Eur J Pharmacol 966:176334. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176334","journal-title":"Eur J Pharmacol"},{"key":"4541_CR359","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S1359-6446(04)03061-2","volume":"9","author":"W Xie","year":"2004","unstructured":"Xie W, Uppal H, Saini SPS, Mu Y, Little JM, Radominska-Pandya A, Zemaitis MA (2004) Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism. Drug Discov Today 9:442\u2013449. https:\/\/doi.org\/10.1016\/S1359-6446(04)03061-2","journal-title":"Drug Discov Today"},{"key":"4541_CR360","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1194\/jlr.M500532-jlr200","volume":"47","author":"H Yamaguchi","year":"2006","unstructured":"Yamaguchi H, Okada M, Akitaya S, Ohara H, Mikkaichi T, Ishikawa H, Sato M, Matsuura M, Saga T, Unno M, Abe T, Mano N, Hishinuma T, Goto J (2006) Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3. J Lipid Res 47:1196\u20131202. https:\/\/doi.org\/10.1194\/jlr.M500532-jlr200","journal-title":"J Lipid Res"},{"key":"4541_CR361","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2133\/dmpk.25.214","volume":"25","author":"K Yamaguchi","year":"2010","unstructured":"Yamaguchi K, Murai T, Yabuuchi H, Hui SP, Kurosawa T (2010) Measurement of bile salt export pump transport activities using a fluorescent bile acid derivative. Drug Metab Pharmacokinet 25:214\u2013219. https:\/\/doi.org\/10.2133\/dmpk.25.214","journal-title":"Drug Metab Pharmacokinet"},{"key":"4541_CR362","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1124\/jpet.114.221564","volume":"353","author":"K Yang","year":"2015","unstructured":"Yang K, Pfeifer ND, K\u00f6ck K, Brouwer KLR (2015) Species differences in hepatobiliary disposition of taurocholic acid in human and rat sandwich-cultured hepatocytes: implications for drug-induced liver injury. J Pharmacol Exp Ther 353:415\u2013423. https:\/\/doi.org\/10.1124\/jpet.114.221564","journal-title":"J Pharmacol Exp Ther"},{"key":"4541_CR363","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/toxsci\/kfz088","volume":"170","author":"F Yang","year":"2019","unstructured":"Yang F, Takeuchi T, Tsuneyama K, Yokoi T, Oda S (2019) Experimental evidence of liver injury by BSEP-inhibiting drugs with a bile salt supplementation in rats. Toxicol Sci 170:95\u2013108. https:\/\/doi.org\/10.1093\/toxsci\/kfz088","journal-title":"Toxicol Sci"},{"key":"4541_CR364","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1998.274.4.g757","author":"Y Yoon","year":"1998","unstructured":"Yoon Y, T\u00f6r\u00f6k N, Krueger E, Oswald B, McNiven MA (1998) Ethanol-induced alterations of the microtubule cytoskeleton in hepatocytes. Am J Physiol. https:\/\/doi.org\/10.1152\/ajpgi.1998.274.4.g757","journal-title":"Am J Physiol"},{"key":"4541_CR365","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2181930","volume":"15","author":"L Yu","year":"2023","unstructured":"Yu L, Liu Y, Wang S, Zhang Q, Zhao J, Zhang H, Narbad A, Tian F, Zhai Q, Chen W (2023) Cholestasis: exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies. Gut Microbes 15:2181930. https:\/\/doi.org\/10.1080\/19490976.2023.2181930","journal-title":"Gut Microbes"},{"issue":"1","key":"4541_CR366","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s42003-025-08928-6","volume":"8","author":"S Yuan","year":"2025","unstructured":"Yuan S, Zhang P, Yang S, Chen J, Mu X, Wu C, Deng J (2025) Targeted cellular depletion in an immune-liver-on-a-chip platform elucidates cell-type-specific heterogeneity in drug-induced hepatotoxicity. Commun Biol 8(1):1560. https:\/\/doi.org\/10.1038\/s42003-025-08928-6","journal-title":"Commun Biol"},{"key":"4541_CR367","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1124\/jpet.102.044107","volume":"304","author":"MJ Zamek-Gliszczynski","year":"2003","unstructured":"Zamek-Gliszczynski MJ, Xiong H, Patel NJ, Turncliff RZ, Pollack GM, Brouwer KLR (2003) Pharmacokinetics of 5 (and 6)-carboxy-2\u2019,7\u2019-dichlorofluorescein and its diacetate promoiety in the liver. J Pharmacol Exp Ther 304:801\u2013809. https:\/\/doi.org\/10.1124\/jpet.102.044107","journal-title":"J Pharmacol Exp Ther"},{"key":"4541_CR368","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/path.1649","volume":"204","author":"K Zatloukal","year":"2004","unstructured":"Zatloukal K, Stumptner C, Fuchsbichler A, Fickert P, Lackner C, Trauner M, Denk H (2004) The keratin cytoskeleton in liver diseases. J Pathol 204:367\u2013376. https:\/\/doi.org\/10.1002\/path.1649","journal-title":"J Pathol"},{"key":"4541_CR369","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bbrc.2004.11.005","volume":"326","author":"GH Zhang","year":"2004","unstructured":"Zhang GH, Cong AR, Xu GB, Li CB, Yang RF, Xia TA (2004) An enzymatic cycling method for the determination of serum total bile acids with recombinant 3\u03b1-hydroxysteroid dehydrogenase. Biochem Biophys Res Commun 326:87\u201392. https:\/\/doi.org\/10.1016\/j.bbrc.2004.11.005","journal-title":"Biochem Biophys Res Commun"},{"key":"4541_CR370","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cbi.2016.03.019","volume":"255","author":"J Zhang","year":"2016","unstructured":"Zhang J, He K, Cai L, Chen YC, Yang Y, Shi Q, Woolf TF, Ge W, Guo L, Borlak J, Tong W (2016) Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse. Chem Biol Interact 255:45. https:\/\/doi.org\/10.1016\/j.cbi.2016.03.019","journal-title":"Chem Biol Interact"},{"key":"4541_CR371","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s11658-024-00673-8","volume":"29","author":"L Zhang","year":"2024","unstructured":"Zhang L, Zou W, Zhang S, Wu H, Gao Y, Zhang J, Zheng J (2024) Maternal high-fat diet orchestrates offspring hepatic cholesterol metabolism via MEF2A hypermethylation-mediated CYP7A1 suppression. Cell Mol Biol Lett 29:154-. https:\/\/doi.org\/10.1186\/s11658-024-00673-8","journal-title":"Cell Mol Biol Lett"},{"key":"4541_CR372","doi-asserted-by":"publisher","DOI":"10.1016\/J.ACA.2021.338305","volume":"1153","author":"QH Zhou","year":"2021","unstructured":"Zhou QH, Lv X, Tian ZH, Finel M, Feng L, Huo PC, Zhu YD, Lu Y, Hou J, Ge GB (2021) A fluorescence-based microplate assay for high-throughput screening and evaluation of human UGT inhibitors. Anal Chim Acta 1153:338305. https:\/\/doi.org\/10.1016\/J.ACA.2021.338305","journal-title":"Anal Chim Acta"},{"key":"4541_CR373","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics16050726","volume":"16","author":"I Ziccardi","year":"2026","unstructured":"Ziccardi I, Zorzi M, d\u2019Adamo AP (2026) Beyond the pump: the evolving molecular landscape of intrahepatic cholestasis. Diagnostics 16:726. https:\/\/doi.org\/10.3390\/diagnostics16050726","journal-title":"Diagnostics"},{"issue":"13","key":"4541_CR374","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/S10354-006-0312-7","volume":"156","author":"G Zollner","year":"2006","unstructured":"Zollner G, Trauner M (2006) Molecular mechanisms of cholestasis. Wien Med Wochenschr 156(13):380\u2013385. https:\/\/doi.org\/10.1007\/S10354-006-0312-7","journal-title":"Wien Med Wochenschr"},{"key":"4541_CR375","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1476-5381.2008.00030.x","volume":"156","author":"G Zollner","year":"2009","unstructured":"Zollner G, Trauner M (2009) Nuclear receptors as therapeutic targets in cholestatic liver diseases. Br J Pharmacol 156:7","journal-title":"Br J Pharmacol"},{"key":"4541_CR376","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1021\/mp060010s","volume":"3","author":"G Zollner","year":"2006","unstructured":"Zollner G, Marschall HU, Wagner M, Trauner M (2006) Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm 3:231\u2013251. https:\/\/doi.org\/10.1021\/mp060010s","journal-title":"Mol Pharm"},{"key":"4541_CR377","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/J.1478-3231.2007.01506.X;PAGE:STRING:ARTICLE\/CHAPTER","volume":"27","author":"G Zollner","year":"2007","unstructured":"Zollner G, Wagner M, Fickert P, Silbert D, Gumhold J, Zatloukal K, Denk H, Trauner M (2007) Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver Int 27:920\u2013929. https:\/\/doi.org\/10.1111\/J.1478-3231.2007.01506.X;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"Liver Int"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04541-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04541-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04541-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:19:06Z","timestamp":1790583546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-026-04541-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":377,"alternative-id":["4541"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04541-6","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"14 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}